Gene Symbol | Gene ID | Gene Info |
---|---|---|
Osr2
|
ENSMUSG00000022330.4 | odd-skipped related 2 |
Osr1
|
ENSMUSG00000048387.7 | odd-skipped related transcription factor 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr12_9574410_9574823 | Osr1 | 175 | 0.944454 | -0.76 | 2.5e-11 | Click! |
chr12_9574076_9574353 | Osr1 | 227 | 0.923623 | -0.68 | 1.6e-08 | Click! |
chr12_9587854_9588005 | Osr1 | 13488 | 0.171920 | -0.50 | 9.7e-05 | Click! |
chr12_9550448_9550599 | Osr1 | 19593 | 0.149757 | -0.45 | 5.7e-04 | Click! |
chr12_9584580_9585090 | Osr1 | 10394 | 0.177016 | -0.28 | 3.6e-02 | Click! |
chr15_35286801_35286981 | Osr2 | 9207 | 0.201546 | -0.72 | 6.9e-10 | Click! |
chr15_35271720_35271871 | Osr2 | 24303 | 0.175140 | -0.60 | 1.5e-06 | Click! |
chr15_35295929_35296626 | Osr2 | 166 | 0.955559 | -0.58 | 3.7e-06 | Click! |
chr15_35268844_35268995 | Osr2 | 27179 | 0.169041 | -0.55 | 1.3e-05 | Click! |
chr15_35285068_35285219 | Osr2 | 10955 | 0.198125 | -0.53 | 3.6e-05 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr7_103910571_103910996 | 15.59 |
Olfr65 |
olfactory receptor 65 |
4441 |
0.07 |
chr16_49771611_49771888 | 9.77 |
Gm15518 |
predicted gene 15518 |
27121 |
0.19 |
chrX_142359130_142359442 | 9.76 |
Acsl4 |
acyl-CoA synthetase long-chain family member 4 |
31058 |
0.12 |
chr15_76252839_76253010 | 9.67 |
Mir6953 |
microRNA 6953 |
4733 |
0.08 |
chr2_125617408_125617804 | 9.65 |
Cep152 |
centrosomal protein 152 |
7507 |
0.23 |
chr2_6331309_6331868 | 8.91 |
AL845275.1 |
novel protein |
8508 |
0.19 |
chr5_8894851_8895125 | 8.85 |
Abcb4 |
ATP-binding cassette, sub-family B (MDR/TAP), member 4 |
1039 |
0.47 |
chr13_14033395_14033670 | 8.64 |
Tbce |
tubulin-specific chaperone E |
6047 |
0.13 |
chr11_75270709_75270875 | 8.36 |
Gm47300 |
predicted gene, 47300 |
47816 |
0.08 |
chr1_161792328_161792513 | 8.26 |
Fasl |
Fas ligand (TNF superfamily, member 6) |
3925 |
0.17 |
chr18_80260075_80260396 | 8.07 |
Slc66a2 |
solute carrier family 66 member 2 |
2605 |
0.17 |
chr7_65639995_65640168 | 8.07 |
Gm7546 |
predicted gene 7546 |
4168 |
0.2 |
chr13_109652180_109652468 | 8.02 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
19544 |
0.3 |
chr11_11885361_11885530 | 8.00 |
Ddc |
dopa decarboxylase |
4816 |
0.19 |
chr5_123223029_123223358 | 7.98 |
Psmd9 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 9 |
4997 |
0.12 |
chr16_49775085_49775373 | 7.89 |
Gm15518 |
predicted gene 15518 |
23641 |
0.2 |
chr14_121365973_121366157 | 7.70 |
Stk24 |
serine/threonine kinase 24 |
6197 |
0.22 |
chr7_78798153_78798431 | 7.62 |
Mrpl46 |
mitochondrial ribosomal protein L46 |
14761 |
0.11 |
chr10_28422667_28422825 | 7.55 |
Ptprk |
protein tyrosine phosphatase, receptor type, K |
137405 |
0.05 |
chr13_113859108_113859271 | 7.50 |
Arl15 |
ADP-ribosylation factor-like 15 |
64567 |
0.1 |
chr3_59058975_59059256 | 7.42 |
Gpr171 |
G protein-coupled receptor 171 |
42706 |
0.1 |
chr4_32570992_32571180 | 7.30 |
Bach2os |
BTB and CNC homology 2, opposite strand |
531 |
0.72 |
chr8_31720101_31720377 | 7.30 |
Gm5117 |
predicted gene 5117 |
19521 |
0.24 |
chr6_88760188_88760364 | 7.27 |
Gm43999 |
predicted gene, 43999 |
17549 |
0.11 |
chr10_53435734_53435898 | 7.20 |
Gm36229 |
predicted gene, 36229 |
25934 |
0.12 |
chr11_110463266_110463565 | 7.14 |
Map2k6 |
mitogen-activated protein kinase kinase 6 |
13962 |
0.27 |
chr18_32542304_32542816 | 7.14 |
Gypc |
glycophorin C |
7142 |
0.21 |
chr3_95588367_95588556 | 7.01 |
Golph3l |
golgi phosphoprotein 3-like |
473 |
0.43 |
chr12_32110648_32110840 | 6.88 |
5430401H09Rik |
RIKEN cDNA 5430401H09 gene |
12958 |
0.18 |
chr6_140946871_140947164 | 6.87 |
Gm30524 |
predicted gene, 30524 |
8592 |
0.26 |
chr18_61960597_61960886 | 6.67 |
Sh3tc2 |
SH3 domain and tetratricopeptide repeats 2 |
7657 |
0.21 |
chr4_115848899_115849232 | 6.61 |
Mknk1 |
MAP kinase-interacting serine/threonine kinase 1 |
7967 |
0.12 |
chr7_63952612_63952794 | 6.60 |
Gm44627 |
predicted gene 44627 |
4025 |
0.16 |
chrX_7057188_7057347 | 6.58 |
Akap4 |
A kinase (PRKA) anchor protein 4 |
10252 |
0.19 |
chr13_111684161_111684322 | 6.56 |
Mier3 |
MIER family member 3 |
1937 |
0.28 |
chr8_65617940_65618821 | 6.56 |
Marchf1 |
membrane associated ring-CH-type finger 1 |
145 |
0.97 |
chr1_36919717_36920078 | 6.55 |
Gm38115 |
predicted gene, 38115 |
3358 |
0.17 |
chr13_45527745_45527917 | 6.54 |
Gmpr |
guanosine monophosphate reductase |
10978 |
0.24 |
chr11_51404087_51404246 | 6.49 |
Col23a1 |
collagen, type XXIII, alpha 1 |
114246 |
0.05 |
chr6_149194117_149194285 | 6.40 |
Amn1 |
antagonist of mitotic exit network 1 |
5489 |
0.16 |
chr3_125279193_125279363 | 6.39 |
Gm42826 |
predicted gene 42826 |
59725 |
0.16 |
chr5_112302279_112302623 | 6.33 |
Tpst2 |
protein-tyrosine sulfotransferase 2 |
1445 |
0.28 |
chr1_157243934_157244109 | 6.24 |
Rasal2 |
RAS protein activator like 2 |
469 |
0.85 |
chr3_154091552_154091734 | 6.19 |
Gm3076 |
predicted gene 3076 |
40697 |
0.13 |
chr3_88205532_88206477 | 6.19 |
Gm3764 |
predicted gene 3764 |
809 |
0.34 |
chr1_173332520_173332681 | 6.16 |
Ackr1 |
atypical chemokine receptor 1 (Duffy blood group) |
902 |
0.5 |
chr18_41942850_41943121 | 6.13 |
Prelid2 |
PRELI domain containing 2 |
8209 |
0.21 |
chr11_44469603_44469912 | 6.09 |
Ublcp1 |
ubiquitin-like domain containing CTD phosphatase 1 |
741 |
0.4 |
chr3_79538416_79538614 | 6.06 |
Fnip2 |
folliculin interacting protein 2 |
6639 |
0.15 |
chr6_19283048_19283211 | 6.06 |
4930524B17Rik |
RIKEN cDNA 4930524B17 gene |
4286 |
0.3 |
chr6_148513212_148513612 | 6.06 |
Tmtc1 |
transmembrane and tetratricopeptide repeat containing 1 |
69023 |
0.09 |
chr17_43592823_43592984 | 5.98 |
1700071M16Rik |
RIKEN cDNA 1700071M16 gene |
461 |
0.78 |
chr6_116086165_116086341 | 5.98 |
Tmcc1 |
transmembrane and coiled coil domains 1 |
13097 |
0.16 |
chr5_44196296_44196466 | 5.98 |
Tapt1 |
transmembrane anterior posterior transformation 1 |
4259 |
0.13 |
chr10_54039973_54040637 | 5.95 |
Gm47917 |
predicted gene, 47917 |
23506 |
0.18 |
chr2_172348383_172348885 | 5.92 |
Fam210b |
family with sequence similarity 210, member B |
3069 |
0.17 |
chr3_95230618_95231095 | 5.83 |
Mllt11 |
myeloid/lymphoid or mixed-lineage leukemia; translocated to, 11 |
384 |
0.64 |
chr4_110284803_110284954 | 5.75 |
Elavl4 |
ELAV like RNA binding protein 4 |
1738 |
0.51 |
chr9_103326465_103326728 | 5.75 |
Topbp1 |
topoisomerase (DNA) II binding protein 1 |
1214 |
0.42 |
chr10_68156329_68156523 | 5.71 |
Arid5b |
AT rich interactive domain 5B (MRF1-like) |
19800 |
0.24 |
chr6_144570995_144571169 | 5.63 |
Sox5os2 |
SRY (sex determining region Y)-box 5, opposite strand 2 |
89857 |
0.08 |
chr17_6804856_6805157 | 5.61 |
4933426B08Rik |
RIKEN cDNA 4933426B08 gene |
3503 |
0.19 |
chr9_43115839_43116036 | 5.57 |
Tlcd5 |
TLC domain containing 5 |
596 |
0.72 |
chr2_135541067_135541625 | 5.53 |
9630028H03Rik |
RIKEN cDNA 9630028H03 gene |
41950 |
0.18 |
chr3_137968129_137968281 | 5.50 |
Dapp1 |
dual adaptor for phosphotyrosine and 3-phosphoinositides 1 |
12338 |
0.12 |
chr1_167384518_167384727 | 5.49 |
Mgst3 |
microsomal glutathione S-transferase 3 |
9219 |
0.15 |
chr1_165396815_165396966 | 5.47 |
Dcaf6 |
DDB1 and CUL4 associated factor 6 |
8129 |
0.14 |
chr14_121447162_121447357 | 5.46 |
Gm33299 |
predicted gene, 33299 |
8503 |
0.19 |
chr6_17797574_17797931 | 5.43 |
Gm26738 |
predicted gene, 26738 |
37433 |
0.13 |
chr2_91710778_91711057 | 5.41 |
Harbi1 |
harbinger transposase derived 1 |
0 |
0.83 |
chr12_27680639_27680801 | 5.40 |
Gm24326 |
predicted gene, 24326 |
48917 |
0.17 |
chr11_110463651_110463811 | 5.40 |
Map2k6 |
mitogen-activated protein kinase kinase 6 |
13646 |
0.27 |
chr4_154929190_154929525 | 5.40 |
Tnfrsf14 |
tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator) |
794 |
0.51 |
chr2_158588848_158589178 | 5.39 |
Gm14204 |
predicted gene 14204 |
21577 |
0.11 |
chr6_84841196_84841459 | 5.38 |
Gm7507 |
predicted gene 7507 |
29087 |
0.18 |
chr9_35105556_35106095 | 5.38 |
St3gal4 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 4 |
842 |
0.54 |
chr5_139805983_139806169 | 5.35 |
Tmem184a |
transmembrane protein 184a |
1904 |
0.22 |
chr6_143166517_143167346 | 5.35 |
Etnk1 |
ethanolamine kinase 1 |
290 |
0.88 |
chr17_45593893_45594163 | 5.34 |
Slc29a1 |
solute carrier family 29 (nucleoside transporters), member 1 |
388 |
0.72 |
chr2_106735898_106736058 | 5.29 |
Mpped2 |
metallophosphoesterase domain containing 2 |
5488 |
0.27 |
chr15_77977768_77977930 | 5.29 |
Eif3d |
eukaryotic translation initiation factor 3, subunit D |
7036 |
0.16 |
chr11_100759963_100760128 | 5.25 |
Kcnh4 |
potassium voltage-gated channel, subfamily H (eag-related), member 4 |
103 |
0.93 |
chr6_120956690_120957084 | 5.23 |
Mical3 |
microtubule associated monooxygenase, calponin and LIM domain containing 3 |
836 |
0.46 |
chr14_46597115_46597271 | 5.22 |
Rubie |
RNA upstream of Bmp4 expressed in inner ear |
1232 |
0.34 |
chr14_51144018_51144178 | 5.11 |
1810028F09Rik |
RIKEN cDNA 1810028F09 gene |
19 |
0.94 |
chr4_10874725_10875127 | 5.08 |
2610301B20Rik |
RIKEN cDNA 2610301B20 gene |
358 |
0.71 |
chr9_66504065_66504251 | 5.08 |
Herc1 |
HECT and RLD domain containing E3 ubiquitin protein ligase family member 1 |
3904 |
0.2 |
chr1_160287060_160287241 | 5.08 |
Rabgap1l |
RAB GTPase activating protein 1-like |
188 |
0.92 |
chr19_42583090_42583271 | 5.06 |
R3hcc1l |
R3H domain and coiled-coil containing 1 like |
2019 |
0.31 |
chr7_96778767_96778949 | 5.05 |
Tenm4 |
teneurin transmembrane protein 4 |
924 |
0.56 |
chr2_121660970_121661121 | 5.05 |
Gm14021 |
predicted gene 14021 |
40680 |
0.13 |
chr11_16503560_16503934 | 5.04 |
Sec61g |
SEC61, gamma subunit |
1297 |
0.48 |
chr6_103508259_103508556 | 4.98 |
Chl1 |
cell adhesion molecule L1-like |
2179 |
0.29 |
chr11_121434218_121434457 | 4.95 |
Fn3k |
fructosamine 3 kinase |
576 |
0.65 |
chr3_131283448_131283608 | 4.94 |
Gm18492 |
predicted gene, 18492 |
1616 |
0.31 |
chr8_72655022_72655548 | 4.92 |
Nwd1 |
NACHT and WD repeat domain containing 1 |
1799 |
0.29 |
chr13_109682772_109683058 | 4.92 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
3241 |
0.4 |
chr13_19178438_19178649 | 4.91 |
Gm31887 |
predicted gene, 31887 |
15015 |
0.21 |
chr19_53965032_53965401 | 4.90 |
Gm50273 |
predicted gene, 50273 |
2447 |
0.22 |
chr11_78500820_78501107 | 4.90 |
Vtn |
vitronectin |
357 |
0.69 |
chr4_49559801_49560414 | 4.88 |
Aldob |
aldolase B, fructose-bisphosphate |
10561 |
0.14 |
chr11_117832421_117832818 | 4.85 |
Afmid |
arylformamidase |
346 |
0.73 |
chrX_85580892_85581069 | 4.84 |
Tab3 |
TGF-beta activated kinase 1/MAP3K7 binding protein 3 |
6830 |
0.22 |
chr5_140023951_140024166 | 4.83 |
Gm43702 |
predicted gene 43702 |
8118 |
0.18 |
chr2_63962810_63962988 | 4.82 |
Fign |
fidgetin |
135089 |
0.06 |
chr10_95297705_95298060 | 4.81 |
Gm48880 |
predicted gene, 48880 |
16971 |
0.14 |
chr14_57350226_57350387 | 4.81 |
Gm8971 |
predicted gene 8971 |
13079 |
0.14 |
chr11_107867530_107867705 | 4.76 |
Gm27595 |
predicted gene, 27595 |
15872 |
0.17 |
chr14_25534543_25534722 | 4.76 |
Mir3075 |
microRNA 3075 |
193 |
0.94 |
chr10_81092585_81092876 | 4.68 |
Creb3l3 |
cAMP responsive element binding protein 3-like 3 |
155 |
0.88 |
chr15_98115995_98116146 | 4.67 |
Pfkm |
phosphofructokinase, muscle |
7604 |
0.12 |
chr16_13329692_13330040 | 4.63 |
Mrtfb |
myocardin related transcription factor B |
28555 |
0.19 |
chr6_103666041_103666194 | 4.61 |
Chl1 |
cell adhesion molecule L1-like |
31633 |
0.16 |
chr15_97786042_97786397 | 4.61 |
Slc48a1 |
solute carrier family 48 (heme transporter), member 1 |
1730 |
0.26 |
chr8_35567247_35567548 | 4.59 |
Mfhas1 |
malignant fibrous histiocytoma amplified sequence 1 |
20401 |
0.17 |
chr11_80518364_80518870 | 4.57 |
C030013C21Rik |
RIKEN cDNA C030013C21 gene |
9511 |
0.21 |
chr13_35786430_35786581 | 4.56 |
Gm48708 |
predicted gene, 48708 |
9609 |
0.17 |
chr2_30772560_30773216 | 4.54 |
1700001O22Rik |
RIKEN cDNA 1700001O22 gene |
23776 |
0.11 |
chr4_57311890_57312041 | 4.54 |
Ptpn3 |
protein tyrosine phosphatase, non-receptor type 3 |
10128 |
0.18 |
chr15_75975781_75976091 | 4.53 |
Zfp707 |
zinc finger protein 707 |
3153 |
0.1 |
chr3_101367521_101367681 | 4.49 |
Igsf3 |
immunoglobulin superfamily, member 3 |
9482 |
0.15 |
chr10_84700303_84700580 | 4.48 |
Rfx4 |
regulatory factor X, 4 (influences HLA class II expression) |
55621 |
0.1 |
chr4_151024275_151024435 | 4.47 |
Per3 |
period circadian clock 3 |
7142 |
0.16 |
chr18_36560129_36560675 | 4.47 |
Ankhd1 |
ankyrin repeat and KH domain containing 1 |
209 |
0.91 |
chr17_35104821_35105105 | 4.46 |
Ly6g5c |
lymphocyte antigen 6 complex, locus G5C |
3316 |
0.06 |
chr12_69733638_69733791 | 4.46 |
Dmac2l |
distal membrane arm assembly complex 2 like |
8724 |
0.13 |
chr13_76055426_76056750 | 4.43 |
Gpr150 |
G protein-coupled receptor 150 |
908 |
0.49 |
chr15_35201554_35201727 | 4.42 |
Gm33497 |
predicted gene, 33497 |
836 |
0.66 |
chr4_63229911_63230518 | 4.39 |
Col27a1 |
collagen, type XXVII, alpha 1 |
4072 |
0.2 |
chr5_118480054_118480344 | 4.38 |
Gm15754 |
predicted gene 15754 |
6768 |
0.21 |
chr12_80817920_80818091 | 4.38 |
Susd6 |
sushi domain containing 6 |
27446 |
0.12 |
chr13_78937424_78937962 | 4.36 |
Gm8345 |
predicted gene 8345 |
17099 |
0.29 |
chr11_49981331_49981667 | 4.34 |
Rasgef1c |
RasGEF domain family, member 1C |
17714 |
0.17 |
chr13_20151466_20151636 | 4.33 |
Elmo1 |
engulfment and cell motility 1 |
33656 |
0.22 |
chr2_71366751_71366902 | 4.32 |
Slc25a12 |
solute carrier family 25 (mitochondrial carrier, Aralar), member 12 |
707 |
0.64 |
chr12_4501977_4502149 | 4.32 |
2900045O20Rik |
RIKEN cDNA 2900045O20 gene |
7254 |
0.15 |
chr5_34976672_34977186 | 4.31 |
Rgs12 |
regulator of G-protein signaling 12 |
1937 |
0.3 |
chr16_27387785_27388183 | 4.30 |
Ccdc50 |
coiled-coil domain containing 50 |
885 |
0.61 |
chr14_119007577_119007764 | 4.30 |
Uggt2 |
UDP-glucose glycoprotein glucosyltransferase 2 |
114 |
0.97 |
chr3_152928812_152928963 | 4.30 |
Gm16213 |
predicted gene 16213 |
8647 |
0.17 |
chr2_91949584_91949971 | 4.28 |
Dgkz |
diacylglycerol kinase zeta |
534 |
0.65 |
chr5_62813834_62814023 | 4.27 |
Dthd1 |
death domain containing 1 |
105 |
0.98 |
chr12_35663108_35663387 | 4.27 |
9130015A21Rik |
RIKEN cDNA 9130015A21 gene |
11256 |
0.2 |
chr10_77211136_77211324 | 4.26 |
Col18a1 |
collagen, type XVIII, alpha 1 |
44682 |
0.11 |
chr7_143600011_143600648 | 4.25 |
Gm15579 |
predicted gene 15579 |
195 |
0.53 |
chr15_62221522_62221691 | 4.24 |
Pvt1 |
Pvt1 oncogene |
997 |
0.57 |
chr16_90822664_90822840 | 4.24 |
Eva1c |
eva-1 homolog C (C. elegans) |
3967 |
0.17 |
chr7_144523398_144523608 | 4.23 |
Ppfia1 |
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 1 |
867 |
0.58 |
chr4_139335538_139335703 | 4.22 |
AL807811.1 |
aldo-keto reductase family 7 member A2 (AKR7A2) pseudogene |
1560 |
0.18 |
chr5_66470962_66471113 | 4.21 |
Apbb2 |
amyloid beta (A4) precursor protein-binding, family B, member 2 |
21134 |
0.13 |
chr1_165775630_165775900 | 4.18 |
Gm36972 |
predicted gene, 36972 |
1390 |
0.23 |
chr10_10449180_10449344 | 4.15 |
Gm48326 |
predicted gene, 48326 |
16272 |
0.19 |
chr6_29695948_29696300 | 4.15 |
Tspan33 |
tetraspanin 33 |
1890 |
0.32 |
chr2_119593829_119594038 | 4.14 |
Oip5os1 |
Opa interacting protein 5, opposite strand 1 |
364 |
0.78 |
chr11_80335618_80335993 | 4.14 |
Rhbdl3 |
rhomboid like 3 |
10598 |
0.18 |
chr9_110653586_110654769 | 4.13 |
Nbeal2 |
neurobeachin-like 2 |
16 |
0.94 |
chr9_71166429_71166599 | 4.11 |
Aqp9 |
aquaporin 9 |
1119 |
0.45 |
chr11_95339519_95339681 | 4.11 |
Fam117a |
family with sequence similarity 117, member A |
331 |
0.81 |
chr5_72911413_72911564 | 4.09 |
Slain2 |
SLAIN motif family, member 2 |
2816 |
0.19 |
chr3_27201785_27202059 | 4.09 |
Nceh1 |
neutral cholesterol ester hydrolase 1 |
13481 |
0.18 |
chr11_49986744_49986906 | 4.08 |
Rasgef1c |
RasGEF domain family, member 1C |
23040 |
0.15 |
chr19_45802801_45802970 | 4.08 |
Kcnip2 |
Kv channel-interacting protein 2 |
689 |
0.62 |
chr8_122574589_122575129 | 4.07 |
Aprt |
adenine phosphoribosyl transferase |
630 |
0.51 |
chr2_22680070_22680221 | 4.06 |
Gm23636 |
predicted gene, 23636 |
13487 |
0.14 |
chr10_105417004_105417160 | 4.05 |
Gm48203 |
predicted gene, 48203 |
22796 |
0.17 |
chr8_120368693_120369245 | 4.05 |
Gm22715 |
predicted gene, 22715 |
74580 |
0.08 |
chr5_110838046_110838303 | 4.05 |
Hscb |
HscB iron-sulfur cluster co-chaperone |
1401 |
0.26 |
chr4_46454503_46454788 | 4.04 |
Anp32b |
acidic (leucine-rich) nuclear phosphoprotein 32 family, member B |
3743 |
0.16 |
chr3_115856461_115856625 | 4.04 |
Dph5 |
diphthamide biosynthesis 5 |
31294 |
0.11 |
chr1_151619279_151619636 | 4.02 |
Fam129a |
family with sequence similarity 129, member A |
47961 |
0.12 |
chr13_73443929_73444127 | 4.02 |
Lpcat1 |
lysophosphatidylcholine acyltransferase 1 |
23169 |
0.19 |
chr11_11735229_11735403 | 3.99 |
Gm12000 |
predicted gene 12000 |
38877 |
0.13 |
chr2_52557911_52558249 | 3.99 |
Cacnb4 |
calcium channel, voltage-dependent, beta 4 subunit |
480 |
0.81 |
chr7_6883432_6883743 | 3.99 |
Gm44586 |
predicted gene 44586 |
7451 |
0.14 |
chr6_118749357_118749648 | 3.97 |
Cacna1c |
calcium channel, voltage-dependent, L type, alpha 1C subunit |
8472 |
0.27 |
chr9_82713290_82713441 | 3.97 |
Irak1bp1 |
interleukin-1 receptor-associated kinase 1 binding protein 1 |
116175 |
0.06 |
chr17_5111793_5112423 | 3.97 |
Gm15599 |
predicted gene 15599 |
2 |
0.99 |
chr4_98098737_98099093 | 3.96 |
Gm12691 |
predicted gene 12691 |
47684 |
0.17 |
chr7_128460780_128461004 | 3.96 |
Tial1 |
Tia1 cytotoxic granule-associated RNA binding protein-like 1 |
317 |
0.77 |
chr3_9766980_9767261 | 3.95 |
Gm16337 |
predicted gene 16337 |
9513 |
0.22 |
chr2_156983086_156983280 | 3.94 |
Ndrg3 |
N-myc downstream regulated gene 3 |
8744 |
0.11 |
chr9_98299649_98299823 | 3.93 |
Gm28530 |
predicted gene 28530 |
1914 |
0.34 |
chr19_23152821_23152984 | 3.93 |
Mir1192 |
microRNA 1192 |
3471 |
0.2 |
chr9_121916528_121916679 | 3.93 |
Cyp8b1 |
cytochrome P450, family 8, subfamily b, polypeptide 1 |
298 |
0.79 |
chr2_130262373_130262672 | 3.91 |
Nop56 |
NOP56 ribonucleoprotein |
11908 |
0.08 |
chr8_70544198_70544617 | 3.91 |
Ell |
elongation factor RNA polymerase II |
4719 |
0.1 |
chr19_55284094_55284395 | 3.90 |
Acsl5 |
acyl-CoA synthetase long-chain family member 5 |
90 |
0.97 |
chr9_53609969_53610196 | 3.90 |
Acat1 |
acetyl-Coenzyme A acetyltransferase 1 |
248 |
0.9 |
chr14_16380257_16380576 | 3.89 |
Top2b |
topoisomerase (DNA) II beta |
9161 |
0.19 |
chr9_56738591_56739084 | 3.88 |
Lingo1 |
leucine rich repeat and Ig domain containing 1 |
30286 |
0.16 |
chr18_64488012_64488179 | 3.87 |
Fech |
ferrochelatase |
846 |
0.56 |
chr4_62518429_62518651 | 3.87 |
Alad |
aminolevulinate, delta-, dehydratase |
1341 |
0.29 |
chr5_129715645_129715872 | 3.87 |
Mrps17 |
mitochondrial ribosomal protein S17 |
61 |
0.95 |
chr1_180148615_180148897 | 3.86 |
Gm38331 |
predicted gene, 38331 |
605 |
0.7 |
chr1_155790140_155790687 | 3.84 |
Gm37539 |
predicted gene, 37539 |
1289 |
0.33 |
chr5_123202099_123202266 | 3.83 |
Gm43409 |
predicted gene 43409 |
10594 |
0.1 |
chr4_43605427_43605591 | 3.82 |
Gm12472 |
predicted gene 12472 |
17437 |
0.06 |
chr11_31838465_31838969 | 3.80 |
Gm12107 |
predicted gene 12107 |
6057 |
0.2 |
chr11_54596004_54596155 | 3.80 |
Rapgef6 |
Rap guanine nucleotide exchange factor (GEF) 6 |
67 |
0.98 |
chr5_30154514_30155097 | 3.79 |
Hadha |
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha |
157 |
0.77 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 6.0 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
1.9 | 5.7 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
1.5 | 3.0 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
1.5 | 4.4 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
1.4 | 4.1 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
1.3 | 6.6 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
1.3 | 3.8 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
1.2 | 4.9 | GO:0008228 | opsonization(GO:0008228) |
1.2 | 7.3 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
1.2 | 3.5 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
1.2 | 6.9 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
1.1 | 3.3 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
1.1 | 5.3 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
1.0 | 4.2 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
1.0 | 3.1 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
1.0 | 4.1 | GO:0042420 | dopamine catabolic process(GO:0042420) |
1.0 | 3.0 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.9 | 3.7 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.9 | 3.7 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
0.9 | 3.7 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.9 | 2.7 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.9 | 2.7 | GO:0034093 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.9 | 2.7 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.9 | 2.6 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.8 | 2.5 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.8 | 2.4 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.8 | 3.2 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.8 | 4.0 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.8 | 2.4 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.8 | 0.8 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.8 | 3.1 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.8 | 5.4 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.8 | 2.3 | GO:0090579 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
0.7 | 2.2 | GO:0034476 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) |
0.7 | 2.9 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.7 | 2.2 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.7 | 1.4 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.7 | 2.1 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.7 | 2.1 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.7 | 2.8 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.7 | 8.3 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.7 | 2.1 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.7 | 0.7 | GO:2001012 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.7 | 4.0 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.7 | 2.7 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.7 | 3.3 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.6 | 10.4 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.6 | 1.9 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.6 | 2.6 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.6 | 2.5 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.6 | 1.3 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.6 | 1.9 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.6 | 2.4 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.6 | 1.2 | GO:0052422 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.6 | 0.6 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
0.6 | 1.8 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.6 | 2.4 | GO:1903238 | positive regulation of leukocyte tethering or rolling(GO:1903238) |
0.6 | 2.3 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.6 | 2.3 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.6 | 1.7 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
0.6 | 2.9 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.6 | 4.5 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.6 | 2.3 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
0.6 | 1.1 | GO:0072611 | interleukin-5 secretion(GO:0072603) interleukin-13 secretion(GO:0072611) regulation of interleukin-5 secretion(GO:2000662) regulation of interleukin-13 secretion(GO:2000665) |
0.6 | 1.7 | GO:0021553 | olfactory nerve development(GO:0021553) |
0.6 | 2.2 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.5 | 2.2 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.5 | 1.6 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.5 | 0.5 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.5 | 1.6 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.5 | 0.5 | GO:1900045 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.5 | 3.2 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.5 | 3.1 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.5 | 4.2 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.5 | 1.6 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.5 | 1.0 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.5 | 3.6 | GO:0019441 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.5 | 0.5 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.5 | 1.5 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.5 | 2.0 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.5 | 2.0 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) |
0.5 | 0.5 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
0.5 | 4.5 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.5 | 4.9 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.5 | 2.0 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.5 | 1.5 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.5 | 1.0 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
0.5 | 1.0 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.5 | 2.0 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.5 | 2.4 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.5 | 1.9 | GO:0097460 | ferrous iron import into cell(GO:0097460) |
0.5 | 5.3 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.5 | 2.4 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.5 | 0.5 | GO:0061724 | lipophagy(GO:0061724) |
0.5 | 0.9 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.5 | 1.4 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.5 | 1.4 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
0.5 | 0.9 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
0.5 | 1.9 | GO:0032202 | telomere assembly(GO:0032202) |
0.5 | 1.4 | GO:1901162 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.5 | 1.4 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.5 | 0.5 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.5 | 1.8 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.5 | 0.9 | GO:1904688 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.5 | 2.7 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.4 | 4.5 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.4 | 1.3 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.4 | 0.9 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.4 | 2.2 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.4 | 7.0 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.4 | 3.1 | GO:0032782 | bile acid secretion(GO:0032782) |
0.4 | 0.9 | GO:0015684 | ferrous iron transport(GO:0015684) |
0.4 | 1.7 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.4 | 0.4 | GO:0015817 | histidine transport(GO:0015817) |
0.4 | 4.3 | GO:0019363 | pyridine nucleotide biosynthetic process(GO:0019363) |
0.4 | 1.3 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
0.4 | 2.6 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.4 | 3.4 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.4 | 1.3 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.4 | 0.9 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
0.4 | 1.3 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.4 | 1.3 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.4 | 1.7 | GO:0072525 | pyridine-containing compound biosynthetic process(GO:0072525) |
0.4 | 2.1 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.4 | 2.1 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.4 | 1.7 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.4 | 1.3 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
0.4 | 2.5 | GO:0016266 | O-glycan processing(GO:0016266) |
0.4 | 4.1 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.4 | 3.3 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.4 | 0.8 | GO:1903660 | regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.4 | 1.6 | GO:0043174 | nucleoside salvage(GO:0043174) |
0.4 | 1.2 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.4 | 1.2 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.4 | 0.8 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.4 | 1.2 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.4 | 1.2 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.4 | 1.6 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.4 | 1.2 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.4 | 0.4 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
0.4 | 3.1 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.4 | 0.8 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.4 | 1.2 | GO:0019042 | viral latency(GO:0019042) |
0.4 | 2.7 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.4 | 2.7 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.4 | 1.2 | GO:0090155 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.4 | 1.9 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.4 | 1.2 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.4 | 1.5 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.4 | 5.0 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.4 | 1.5 | GO:0043380 | regulation of memory T cell differentiation(GO:0043380) |
0.4 | 0.8 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.4 | 0.4 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.4 | 1.1 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.4 | 1.1 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.4 | 0.7 | GO:1903421 | regulation of synaptic vesicle recycling(GO:1903421) |
0.4 | 0.4 | GO:0061341 | non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
0.4 | 1.9 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.4 | 1.1 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.4 | 3.0 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.4 | 1.1 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.4 | 1.1 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.4 | 1.1 | GO:0009597 | detection of virus(GO:0009597) |
0.4 | 2.2 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.4 | 1.8 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
0.4 | 1.1 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.4 | 0.4 | GO:0010915 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
0.4 | 2.5 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.4 | 1.4 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.4 | 1.1 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.4 | 0.4 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.4 | 3.2 | GO:0016559 | peroxisome fission(GO:0016559) |
0.4 | 0.7 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
0.4 | 1.1 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.3 | 1.4 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.3 | 2.1 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.3 | 1.4 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.3 | 2.8 | GO:0042168 | heme metabolic process(GO:0042168) |
0.3 | 0.7 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
0.3 | 0.3 | GO:0052428 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.3 | 1.0 | GO:0031627 | telomeric loop formation(GO:0031627) |
0.3 | 1.4 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.3 | 1.4 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.3 | 5.1 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.3 | 2.4 | GO:1902221 | L-phenylalanine metabolic process(GO:0006558) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) |
0.3 | 2.7 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.3 | 0.3 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.3 | 0.3 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.3 | 2.3 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.3 | 2.3 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.3 | 4.0 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.3 | 1.3 | GO:0015886 | heme transport(GO:0015886) |
0.3 | 0.7 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.3 | 1.0 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.3 | 2.0 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.3 | 1.6 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.3 | 1.9 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.3 | 1.6 | GO:0043247 | telomere maintenance in response to DNA damage(GO:0043247) |
0.3 | 1.6 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.3 | 0.6 | GO:0052173 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.3 | 1.0 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.3 | 2.9 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.3 | 0.6 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
0.3 | 1.9 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.3 | 6.0 | GO:0048821 | erythrocyte development(GO:0048821) |
0.3 | 3.4 | GO:0032727 | positive regulation of interferon-alpha production(GO:0032727) |
0.3 | 1.2 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.3 | 0.6 | GO:0007208 | phospholipase C-activating serotonin receptor signaling pathway(GO:0007208) |
0.3 | 2.8 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.3 | 0.9 | GO:0030242 | pexophagy(GO:0030242) |
0.3 | 0.3 | GO:0033239 | negative regulation of cellular amine metabolic process(GO:0033239) |
0.3 | 0.9 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.3 | 1.5 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.3 | 1.2 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.3 | 4.2 | GO:0015858 | nucleoside transport(GO:0015858) |
0.3 | 1.5 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.3 | 1.2 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.3 | 0.6 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.3 | 0.3 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.3 | 4.5 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.3 | 1.2 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.3 | 0.9 | GO:0032484 | Ral protein signal transduction(GO:0032484) |
0.3 | 1.8 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.3 | 0.9 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
0.3 | 2.1 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.3 | 0.6 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.3 | 0.3 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.3 | 0.9 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.3 | 0.9 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.3 | 1.7 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.3 | 0.3 | GO:0039692 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) |
0.3 | 0.9 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.3 | 0.6 | GO:0070350 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
0.3 | 0.9 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.3 | 0.6 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.3 | 0.3 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.3 | 2.3 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.3 | 2.0 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) |
0.3 | 0.6 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
0.3 | 3.1 | GO:0042095 | interferon-gamma biosynthetic process(GO:0042095) |
0.3 | 1.1 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.3 | 0.8 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.3 | 1.4 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.3 | 0.8 | GO:0060596 | mammary placode formation(GO:0060596) |
0.3 | 0.8 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.3 | 4.7 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.3 | 0.8 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.3 | 1.4 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.3 | 0.5 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.3 | 0.8 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.3 | 1.6 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.3 | 0.3 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.3 | 0.8 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.3 | 1.1 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
0.3 | 1.9 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.3 | 0.5 | GO:0090383 | phagosome acidification(GO:0090383) |
0.3 | 1.6 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.3 | 0.8 | GO:0002154 | thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
0.3 | 1.9 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.3 | 0.5 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.3 | 0.8 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.3 | 0.8 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.3 | 0.5 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.3 | 1.1 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.3 | 9.0 | GO:0043039 | tRNA aminoacylation for protein translation(GO:0006418) tRNA aminoacylation(GO:0043039) |
0.3 | 5.0 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
0.3 | 2.4 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.3 | 1.3 | GO:0001835 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.3 | 0.8 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.3 | 0.8 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.3 | 1.3 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.3 | 2.9 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.3 | 0.8 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.3 | 2.3 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.3 | 1.8 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.3 | 0.8 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.3 | 0.5 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.3 | 0.8 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.3 | 0.8 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.3 | 0.3 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.3 | 1.0 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.3 | 0.8 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.3 | 1.3 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.3 | 1.8 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.2 | 4.5 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.2 | 2.2 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.2 | 1.0 | GO:0048478 | replication fork protection(GO:0048478) |
0.2 | 1.7 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.2 | 1.7 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.2 | 1.0 | GO:1901976 | regulation of cell cycle checkpoint(GO:1901976) |
0.2 | 1.2 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.2 | 0.5 | GO:0032776 | DNA methylation on cytosine within a CG sequence(GO:0010424) DNA methylation on cytosine(GO:0032776) |
0.2 | 0.7 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.2 | 1.7 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.2 | 0.5 | GO:0030576 | Cajal body organization(GO:0030576) |
0.2 | 0.7 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.2 | 0.5 | GO:0071281 | cellular response to iron ion(GO:0071281) |
0.2 | 0.5 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
0.2 | 0.7 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
0.2 | 1.0 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.2 | 0.5 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
0.2 | 3.1 | GO:0045116 | protein neddylation(GO:0045116) |
0.2 | 0.7 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.2 | 0.9 | GO:0046645 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.2 | 0.7 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.2 | 0.5 | GO:0061356 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.2 | 0.7 | GO:0010994 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.2 | 0.9 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.2 | 0.9 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.2 | 0.9 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.2 | 1.2 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.2 | 0.7 | GO:0015074 | DNA integration(GO:0015074) |
0.2 | 1.8 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.2 | 4.6 | GO:0071173 | mitotic spindle assembly checkpoint(GO:0007094) spindle assembly checkpoint(GO:0071173) |
0.2 | 1.1 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.2 | 0.2 | GO:2000973 | pro-B cell differentiation(GO:0002328) regulation of pro-B cell differentiation(GO:2000973) |
0.2 | 5.0 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.2 | 0.2 | GO:0010979 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.2 | 0.2 | GO:1902996 | neurofibrillary tangle assembly(GO:1902988) regulation of neurofibrillary tangle assembly(GO:1902996) |
0.2 | 0.5 | GO:0046864 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.2 | 0.7 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
0.2 | 2.3 | GO:0051383 | kinetochore organization(GO:0051383) |
0.2 | 0.5 | GO:0032570 | response to progesterone(GO:0032570) |
0.2 | 0.4 | GO:0071501 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.2 | 1.1 | GO:0006116 | NADH oxidation(GO:0006116) |
0.2 | 2.2 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.2 | 1.1 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.2 | 2.4 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.2 | 0.2 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
0.2 | 2.2 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.2 | 0.4 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.2 | 0.2 | GO:0071971 | extracellular exosome assembly(GO:0071971) |
0.2 | 2.6 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.2 | 1.1 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.2 | 0.6 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.2 | 1.3 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.2 | 0.2 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.2 | 1.1 | GO:0097066 | response to thyroid hormone(GO:0097066) |
0.2 | 0.2 | GO:0032966 | negative regulation of collagen metabolic process(GO:0010713) negative regulation of collagen biosynthetic process(GO:0032966) |
0.2 | 0.4 | GO:0006547 | histidine metabolic process(GO:0006547) |
0.2 | 2.3 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.2 | 1.3 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.2 | 0.2 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.2 | 0.2 | GO:0043038 | amino acid activation(GO:0043038) |
0.2 | 1.5 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.2 | 3.6 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.2 | 0.4 | GO:0010985 | negative regulation of lipoprotein particle clearance(GO:0010985) |
0.2 | 0.2 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.2 | 0.6 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.2 | 1.0 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.2 | 0.6 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.2 | 2.1 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.2 | 2.3 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.2 | 0.4 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.2 | 0.6 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.2 | 0.6 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.2 | 0.8 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.2 | 2.4 | GO:0042407 | cristae formation(GO:0042407) |
0.2 | 0.6 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.2 | 0.4 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.2 | 6.2 | GO:1902653 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
0.2 | 0.2 | GO:0032831 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.2 | 1.2 | GO:0021702 | cerebellar Purkinje cell differentiation(GO:0021702) |
0.2 | 1.4 | GO:0043691 | reverse cholesterol transport(GO:0043691) |
0.2 | 0.2 | GO:0050711 | negative regulation of interleukin-1 secretion(GO:0050711) |
0.2 | 0.2 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.2 | 1.2 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.2 | 0.4 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.2 | 0.4 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.2 | 1.4 | GO:0090169 | regulation of spindle assembly(GO:0090169) |
0.2 | 0.4 | GO:1904261 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.2 | 0.4 | GO:0051031 | tRNA transport(GO:0051031) |
0.2 | 0.6 | GO:0007525 | somatic muscle development(GO:0007525) |
0.2 | 0.2 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
0.2 | 0.6 | GO:0045416 | positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
0.2 | 0.2 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
0.2 | 1.0 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.2 | 3.9 | GO:0035640 | exploration behavior(GO:0035640) |
0.2 | 0.2 | GO:0090382 | phagosome maturation(GO:0090382) |
0.2 | 0.4 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.2 | 1.7 | GO:0016556 | mRNA modification(GO:0016556) |
0.2 | 0.4 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.2 | 0.4 | GO:0070842 | aggresome assembly(GO:0070842) |
0.2 | 0.6 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
0.2 | 1.3 | GO:0097264 | self proteolysis(GO:0097264) |
0.2 | 0.6 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
0.2 | 3.6 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.2 | 2.3 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.2 | 0.4 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.2 | 1.5 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.2 | 1.1 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.2 | 0.6 | GO:0019086 | late viral transcription(GO:0019086) |
0.2 | 1.5 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.2 | 0.9 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.2 | 0.2 | GO:0043366 | beta selection(GO:0043366) |
0.2 | 0.9 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.2 | 0.5 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.2 | 0.2 | GO:1904339 | negative regulation of dopaminergic neuron differentiation(GO:1904339) |
0.2 | 2.4 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.2 | 1.8 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.2 | 0.2 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.2 | 0.9 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.2 | 1.1 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.2 | 1.3 | GO:0043248 | proteasome assembly(GO:0043248) |
0.2 | 0.2 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.2 | 0.7 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.2 | 0.2 | GO:2000969 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.2 | 1.3 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
0.2 | 0.4 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.2 | 0.5 | GO:0090042 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
0.2 | 0.5 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.2 | 1.1 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.2 | 0.4 | GO:0030421 | defecation(GO:0030421) |
0.2 | 0.7 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.2 | 0.7 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
0.2 | 0.2 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.2 | 0.7 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.2 | 0.9 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.2 | 0.3 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.2 | 0.5 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.2 | 0.7 | GO:0036260 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.2 | 1.0 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.2 | 0.3 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.2 | 2.2 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.2 | 0.3 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.2 | 0.5 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.2 | 0.9 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.2 | 1.2 | GO:1902254 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
0.2 | 0.9 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.2 | 0.3 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.2 | 0.5 | GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) |
0.2 | 0.5 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.2 | 0.7 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.2 | 1.0 | GO:0070200 | establishment of protein localization to telomere(GO:0070200) |
0.2 | 0.7 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.2 | 0.3 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.2 | 0.3 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.2 | 7.1 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.2 | 1.2 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.2 | 1.5 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.2 | 0.5 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.2 | 2.5 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.2 | 0.5 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.2 | 2.5 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.2 | 0.3 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.2 | 2.5 | GO:0030488 | tRNA methylation(GO:0030488) |
0.2 | 0.3 | GO:2000832 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.2 | 0.3 | GO:2000489 | regulation of hepatic stellate cell activation(GO:2000489) |
0.2 | 0.2 | GO:1904867 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
0.2 | 0.2 | GO:0032907 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
0.2 | 2.3 | GO:0006298 | mismatch repair(GO:0006298) |
0.2 | 0.3 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.2 | 0.5 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.2 | 0.2 | GO:1903232 | melanosome assembly(GO:1903232) |
0.2 | 0.5 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
0.2 | 0.5 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.2 | 1.3 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.2 | 1.1 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.2 | 0.5 | GO:2000508 | regulation of dendritic cell chemotaxis(GO:2000508) positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.2 | 0.5 | GO:0019448 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.2 | 0.8 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.2 | 1.1 | GO:0048757 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.2 | 1.3 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.2 | 0.2 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.2 | 0.2 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.2 | 1.1 | GO:0098534 | centriole replication(GO:0007099) centriole assembly(GO:0098534) |
0.2 | 0.6 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.2 | 0.3 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.2 | 0.6 | GO:0001812 | positive regulation of type I hypersensitivity(GO:0001812) |
0.2 | 0.6 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.2 | 0.3 | GO:0032898 | neurotrophin production(GO:0032898) |
0.2 | 1.2 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.2 | 0.5 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.2 | 0.2 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.2 | 0.6 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.2 | 0.5 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.2 | 0.2 | GO:1904861 | excitatory synapse assembly(GO:1904861) |
0.2 | 0.2 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) |
0.2 | 0.3 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.2 | 0.5 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.2 | 0.5 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.2 | 0.8 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.2 | 1.7 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.2 | 0.8 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.2 | 0.3 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.2 | 2.7 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.2 | 0.9 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.2 | 1.1 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.1 | 0.9 | GO:0032329 | serine transport(GO:0032329) |
0.1 | 0.4 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.1 | 0.7 | GO:0051013 | microtubule severing(GO:0051013) |
0.1 | 2.1 | GO:0035825 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.1 | 0.4 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
0.1 | 0.1 | GO:1903050 | regulation of proteolysis involved in cellular protein catabolic process(GO:1903050) |
0.1 | 0.4 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.1 | 2.6 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.1 | 0.9 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 1.5 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.1 | 0.6 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.1 | 5.7 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.1 | 0.3 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.1 | 0.1 | GO:2000851 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) positive regulation of cortisol secretion(GO:0051464) positive regulation of glucocorticoid secretion(GO:2000851) |
0.1 | 3.6 | GO:0006414 | translational elongation(GO:0006414) |
0.1 | 0.4 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.1 | 0.6 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.1 | 0.3 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.1 | 1.2 | GO:0040023 | establishment of nucleus localization(GO:0040023) |
0.1 | 0.1 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.1 | 0.3 | GO:0031052 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.1 | 2.6 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.1 | 0.3 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.1 | 0.4 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.1 | 0.6 | GO:0031498 | chromatin disassembly(GO:0031498) |
0.1 | 0.1 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.1 | 0.1 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.1 | 0.4 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
0.1 | 0.4 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.1 | 0.4 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.1 | 3.0 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.1 | 0.1 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.1 | 0.4 | GO:1904729 | regulation of intestinal lipid absorption(GO:1904729) |
0.1 | 1.1 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 0.1 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) |
0.1 | 0.1 | GO:0010165 | response to X-ray(GO:0010165) |
0.1 | 0.7 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.1 | 0.4 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.1 | 0.6 | GO:0015871 | choline transport(GO:0015871) |
0.1 | 0.7 | GO:0097340 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.1 | 0.3 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.1 | 6.4 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.1 | 0.8 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.1 | 0.6 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.1 | 1.1 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 | 0.8 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.1 | 0.6 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.1 | 0.4 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.1 | 1.1 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.1 | 0.1 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.1 | 0.3 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.1 | 0.4 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.1 | 2.5 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.1 | 0.1 | GO:0019614 | catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
0.1 | 1.6 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.1 | 1.2 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.1 | 0.1 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.1 | 1.6 | GO:0097345 | mitochondrial outer membrane permeabilization(GO:0097345) |
0.1 | 0.4 | GO:0015884 | folic acid transport(GO:0015884) |
0.1 | 0.3 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.1 | 7.9 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.1 | 1.3 | GO:0015816 | glycine transport(GO:0015816) |
0.1 | 1.1 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.1 | 0.3 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.1 | 1.6 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.1 | 0.5 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 0.3 | GO:0030260 | entry into host cell(GO:0030260) entry into host(GO:0044409) viral entry into host cell(GO:0046718) entry into cell of other organism involved in symbiotic interaction(GO:0051806) entry into other organism involved in symbiotic interaction(GO:0051828) |
0.1 | 1.1 | GO:0031441 | negative regulation of mRNA 3'-end processing(GO:0031441) |
0.1 | 0.7 | GO:0006266 | DNA ligation(GO:0006266) |
0.1 | 0.4 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.1 | 0.1 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.1 | 0.3 | GO:1903818 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.1 | 1.4 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.1 | 0.5 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.1 | 0.5 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.1 | 0.3 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.1 | 0.5 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.1 | 0.6 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.1 | 0.5 | GO:1902306 | negative regulation of sodium ion transmembrane transport(GO:1902306) |
0.1 | 0.4 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.1 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.1 | 0.5 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.1 | 0.3 | GO:0061620 | glycolytic process through glucose-6-phosphate(GO:0061620) |
0.1 | 1.3 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.1 | 0.1 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.1 | 0.1 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
0.1 | 0.4 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.1 | 2.7 | GO:0042073 | intraciliary transport(GO:0042073) |
0.1 | 1.0 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 0.6 | GO:0060613 | fat pad development(GO:0060613) |
0.1 | 0.5 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.1 | 0.8 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.1 | 0.4 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.1 | 0.4 | GO:0051036 | regulation of endosome size(GO:0051036) |
0.1 | 0.4 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.1 | 0.1 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.1 | 0.9 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.1 | 0.2 | GO:2001225 | regulation of chloride transport(GO:2001225) |
0.1 | 0.4 | GO:0060283 | negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
0.1 | 3.6 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.1 | 1.3 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.1 | 0.4 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.1 | 0.9 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.1 | 0.4 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.1 | 0.1 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.1 | 0.4 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.1 | 0.1 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.1 | 0.7 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.1 | 0.4 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.1 | 1.8 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.1 | 3.1 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
0.1 | 0.4 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.1 | 0.4 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.1 | 0.4 | GO:0015888 | thiamine transport(GO:0015888) |
0.1 | 0.2 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.1 | 0.1 | GO:0035794 | positive regulation of mitochondrial membrane permeability(GO:0035794) |
0.1 | 0.2 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.1 | 0.2 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.1 | 0.4 | GO:0009169 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.1 | 0.1 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.1 | 0.4 | GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.1 | 0.1 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.1 | 0.6 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.1 | 0.2 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 0.2 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.1 | 0.5 | GO:0007144 | female meiosis I(GO:0007144) |
0.1 | 0.1 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
0.1 | 0.5 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.1 | 0.2 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.1 | 0.6 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.1 | 0.2 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.1 | 0.4 | GO:0014048 | regulation of glutamate secretion(GO:0014048) |
0.1 | 10.7 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.1 | 0.5 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 1.2 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.1 | 2.0 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.1 | 0.3 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.1 | 0.8 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.1 | 0.3 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.1 | 0.6 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.1 | 0.2 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.1 | 0.3 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.1 | 0.5 | GO:0033127 | regulation of histone phosphorylation(GO:0033127) |
0.1 | 0.3 | GO:1904872 | regulation of telomerase RNA localization to Cajal body(GO:1904872) positive regulation of telomerase RNA localization to Cajal body(GO:1904874) |
0.1 | 0.2 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.1 | 0.1 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.1 | 0.3 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
0.1 | 0.7 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.1 | 1.0 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 0.2 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.1 | 1.5 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 2.7 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.1 | 0.4 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.1 | 0.3 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.1 | 0.2 | GO:0042297 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
0.1 | 0.3 | GO:0050755 | chemokine metabolic process(GO:0050755) |
0.1 | 0.2 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.1 | 0.3 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
0.1 | 0.3 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.1 | 0.3 | GO:0060618 | nipple development(GO:0060618) |
0.1 | 0.2 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.1 | 0.4 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.1 | 1.0 | GO:0045005 | replication fork processing(GO:0031297) DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
0.1 | 0.1 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.1 | 0.5 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.1 | 0.2 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.1 | 0.7 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
0.1 | 0.2 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.1 | 0.7 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
0.1 | 0.4 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.1 | 0.3 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.1 | 0.3 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.1 | 1.0 | GO:0040001 | establishment of mitotic spindle localization(GO:0040001) |
0.1 | 0.6 | GO:0007614 | short-term memory(GO:0007614) |
0.1 | 0.2 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.1 | 0.4 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.1 | 0.1 | GO:0046084 | adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
0.1 | 0.7 | GO:0051180 | vitamin transport(GO:0051180) |
0.1 | 1.2 | GO:0050779 | RNA destabilization(GO:0050779) |
0.1 | 1.2 | GO:0046549 | retinal cone cell development(GO:0046549) |
0.1 | 0.3 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.1 | 0.2 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.1 | 0.2 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.1 | 0.1 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.1 | 0.5 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.1 | 0.3 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.1 | 0.5 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.3 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
0.1 | 1.0 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.1 | 0.5 | GO:0045821 | positive regulation of glycolytic process(GO:0045821) |
0.1 | 0.6 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.1 | 0.5 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
0.1 | 2.2 | GO:0009651 | response to salt stress(GO:0009651) |
0.1 | 2.9 | GO:0032642 | regulation of chemokine production(GO:0032642) |
0.1 | 1.8 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 1.4 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.1 | 1.3 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.1 | 0.1 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
0.1 | 0.2 | GO:1900117 | regulation of execution phase of apoptosis(GO:1900117) |
0.1 | 0.5 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 0.4 | GO:0010039 | response to iron ion(GO:0010039) |
0.1 | 0.6 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 0.5 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.1 | 0.7 | GO:0050706 | regulation of interleukin-1 secretion(GO:0050704) regulation of interleukin-1 beta secretion(GO:0050706) |
0.1 | 0.6 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.1 | 0.9 | GO:0010259 | multicellular organism aging(GO:0010259) |
0.1 | 1.6 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.1 | 0.4 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.1 | 0.1 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
0.1 | 0.3 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.1 | 0.5 | GO:0033572 | transferrin transport(GO:0033572) |
0.1 | 0.7 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.1 | 0.4 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.1 | 0.2 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.1 | 0.2 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.1 | 0.6 | GO:0030647 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.1 | 0.5 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.1 | 0.1 | GO:0048520 | positive regulation of behavior(GO:0048520) |
0.1 | 0.1 | GO:0048254 | snoRNA localization(GO:0048254) |
0.1 | 0.2 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.6 | GO:0006301 | postreplication repair(GO:0006301) |
0.1 | 0.3 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.1 | 0.4 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.1 | 1.0 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.1 | 0.2 | GO:0033866 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.1 | 0.2 | GO:0098814 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.1 | 0.2 | GO:0034115 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
0.1 | 0.1 | GO:0045829 | negative regulation of isotype switching(GO:0045829) |
0.1 | 0.5 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.1 | 0.4 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 0.1 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.1 | 0.9 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
0.1 | 0.5 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
0.1 | 1.0 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
0.1 | 0.3 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.1 | 0.1 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.1 | 0.1 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.1 | 0.3 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 0.1 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.1 | 0.1 | GO:0090069 | regulation of ribosome biogenesis(GO:0090069) |
0.1 | 0.1 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.1 | 0.3 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.1 | 0.8 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.1 | 0.3 | GO:0014063 | regulation of serotonin secretion(GO:0014062) negative regulation of serotonin secretion(GO:0014063) |
0.1 | 0.3 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.1 | 0.2 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.1 | 0.3 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.1 | 2.7 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.1 | 0.6 | GO:2000757 | negative regulation of protein acetylation(GO:1901984) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.1 | 0.9 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.1 | 0.4 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 0.2 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) |
0.1 | 0.1 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.1 | 0.3 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.1 | 0.1 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.1 | 0.4 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.1 | 1.8 | GO:0009142 | nucleoside triphosphate biosynthetic process(GO:0009142) |
0.1 | 1.9 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
0.1 | 0.4 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
0.1 | 0.4 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.1 | 0.1 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.1 | 0.4 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.1 | 0.1 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.1 | 1.1 | GO:0006284 | base-excision repair(GO:0006284) |
0.1 | 0.3 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.1 | 0.2 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.1 | 0.4 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.1 | 0.1 | GO:0021694 | cerebellar Purkinje cell layer formation(GO:0021694) |
0.1 | 0.4 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
0.1 | 0.5 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 0.2 | GO:1904705 | regulation of vascular smooth muscle cell proliferation(GO:1904705) vascular smooth muscle cell proliferation(GO:1990874) |
0.1 | 0.4 | GO:0021540 | corpus callosum morphogenesis(GO:0021540) |
0.1 | 0.3 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.1 | 0.2 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
0.1 | 0.4 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.1 | 0.3 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.1 | 1.4 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.1 | 0.3 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.1 | 0.3 | GO:1902850 | mitotic spindle assembly(GO:0090307) microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
0.1 | 0.2 | GO:0060526 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.1 | 0.1 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) |
0.1 | 0.1 | GO:0061010 | gall bladder development(GO:0061010) |
0.1 | 0.7 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.1 | 0.7 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.1 | 0.8 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.1 | 0.6 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.1 | 0.1 | GO:2000040 | regulation of planar cell polarity pathway involved in axis elongation(GO:2000040) negative regulation of planar cell polarity pathway involved in axis elongation(GO:2000041) |
0.1 | 0.1 | GO:0060416 | response to growth hormone(GO:0060416) |
0.1 | 0.7 | GO:0034776 | response to histamine(GO:0034776) |
0.1 | 0.2 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.1 | 0.1 | GO:0002034 | regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
0.1 | 0.5 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.1 | 0.2 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.1 | 0.2 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.1 | 0.1 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.1 | 0.1 | GO:1902855 | regulation of nonmotile primary cilium assembly(GO:1902855) |
0.1 | 0.2 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.1 | 0.2 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.1 | 0.3 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.1 | 1.3 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 0.3 | GO:0060337 | type I interferon signaling pathway(GO:0060337) |
0.1 | 4.1 | GO:0000086 | G2/M transition of mitotic cell cycle(GO:0000086) |
0.1 | 0.2 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.1 | 0.4 | GO:0071569 | protein ufmylation(GO:0071569) |
0.1 | 0.2 | GO:0010455 | positive regulation of cell fate commitment(GO:0010455) |
0.1 | 0.6 | GO:0045779 | negative regulation of bone resorption(GO:0045779) |
0.1 | 0.7 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.1 | 0.5 | GO:0098911 | regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
0.1 | 0.5 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.1 | 0.2 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.1 | 2.9 | GO:1902600 | hydrogen ion transmembrane transport(GO:1902600) |
0.1 | 0.1 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.1 | 0.3 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.1 | 0.2 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.1 | 0.1 | GO:0070640 | vitamin D3 metabolic process(GO:0070640) |
0.1 | 0.8 | GO:0070166 | enamel mineralization(GO:0070166) |
0.1 | 0.2 | GO:0070268 | cornification(GO:0070268) |
0.1 | 0.3 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
0.1 | 0.2 | GO:0072025 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
0.1 | 0.4 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.1 | 0.2 | GO:0002585 | positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) |
0.1 | 0.2 | GO:0060005 | vestibular reflex(GO:0060005) |
0.1 | 0.2 | GO:2000121 | regulation of removal of superoxide radicals(GO:2000121) |
0.1 | 0.4 | GO:0071435 | potassium ion export(GO:0071435) |
0.1 | 0.3 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.1 | 0.5 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.1 | 1.8 | GO:0000045 | autophagosome assembly(GO:0000045) |
0.1 | 0.9 | GO:0006826 | iron ion transport(GO:0006826) |
0.1 | 0.1 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.1 | 0.6 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.1 | 0.8 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.1 | 0.1 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.1 | 0.2 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.1 | 0.1 | GO:0030952 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.1 | 0.2 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.1 | 0.3 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.1 | 0.6 | GO:0030449 | regulation of complement activation(GO:0030449) |
0.1 | 0.2 | GO:0098728 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.1 | 0.2 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.1 | 0.6 | GO:0060122 | inner ear receptor stereocilium organization(GO:0060122) |
0.1 | 2.2 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.1 | 0.1 | GO:0031659 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.1 | 0.1 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.1 | 0.3 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.1 | 0.1 | GO:0043133 | hindgut contraction(GO:0043133) regulation of hindgut contraction(GO:0043134) |
0.1 | 0.9 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
0.1 | 0.1 | GO:0034238 | macrophage fusion(GO:0034238) regulation of macrophage fusion(GO:0034239) positive regulation of macrophage fusion(GO:0034241) |
0.1 | 0.1 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.1 | 0.1 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.1 | 0.6 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
0.1 | 0.1 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.1 | 4.2 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.1 | 0.1 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.1 | 0.8 | GO:0016925 | protein sumoylation(GO:0016925) |
0.1 | 1.1 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.1 | 2.5 | GO:0098656 | anion transmembrane transport(GO:0098656) |
0.1 | 0.1 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.1 | 0.3 | GO:0055064 | cellular chloride ion homeostasis(GO:0030644) chloride ion homeostasis(GO:0055064) |
0.1 | 0.1 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.1 | 0.1 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
0.1 | 0.6 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.1 | 0.1 | GO:0002840 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
0.1 | 0.7 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.1 | 0.1 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.1 | 0.4 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.1 | 0.1 | GO:0042938 | dipeptide transport(GO:0042938) |
0.1 | 0.1 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.1 | 0.5 | GO:0042503 | tyrosine phosphorylation of Stat3 protein(GO:0042503) |
0.1 | 0.3 | GO:0009249 | protein lipoylation(GO:0009249) |
0.1 | 0.8 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 0.1 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.1 | 0.1 | GO:0002159 | desmosome assembly(GO:0002159) |
0.1 | 0.2 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.1 | 0.1 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.1 | 0.3 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.1 | 0.5 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.1 | 0.2 | GO:0044784 | metaphase/anaphase transition of mitotic cell cycle(GO:0007091) metaphase/anaphase transition of cell cycle(GO:0044784) |
0.1 | 0.1 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.1 | 0.3 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.1 | 0.3 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.1 | 0.5 | GO:0032365 | intracellular lipid transport(GO:0032365) |
0.1 | 0.1 | GO:0002934 | desmosome organization(GO:0002934) |
0.1 | 0.2 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.1 | 0.2 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 0.1 | GO:0021861 | forebrain radial glial cell differentiation(GO:0021861) |
0.1 | 0.7 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
0.1 | 0.2 | GO:0072366 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
0.1 | 0.4 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.1 | 0.9 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.1 | 0.1 | GO:0050748 | negative regulation of lipoprotein metabolic process(GO:0050748) regulation of protein lipidation(GO:1903059) |
0.1 | 0.2 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.1 | 0.4 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.1 | 0.3 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.1 | 1.5 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.1 | 0.1 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.1 | 0.1 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
0.1 | 0.5 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.1 | 0.1 | GO:0060502 | epithelial cell proliferation involved in lung morphogenesis(GO:0060502) |
0.1 | 0.5 | GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043516) |
0.1 | 0.9 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.1 | 0.2 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.1 | 3.1 | GO:1903747 | regulation of establishment of protein localization to mitochondrion(GO:1903747) |
0.1 | 0.1 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.1 | 0.1 | GO:2000774 | positive regulation of cell aging(GO:0090343) positive regulation of cellular senescence(GO:2000774) |
0.1 | 0.5 | GO:0001675 | acrosome assembly(GO:0001675) |
0.1 | 0.1 | GO:0090290 | positive regulation of osteoclast proliferation(GO:0090290) |
0.1 | 0.6 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
0.1 | 0.4 | GO:0007379 | segment specification(GO:0007379) |
0.1 | 0.6 | GO:0099517 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.1 | 0.1 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.1 | 0.1 | GO:0045625 | regulation of T-helper 1 cell differentiation(GO:0045625) |
0.1 | 0.1 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.1 | 0.1 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.1 | 0.2 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.1 | 0.2 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.1 | 0.2 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.1 | 0.1 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) nucleotide transmembrane transport(GO:1901679) |
0.1 | 0.3 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.1 | 0.1 | GO:0061081 | positive regulation of myeloid leukocyte cytokine production involved in immune response(GO:0061081) |
0.1 | 0.5 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.1 | 0.8 | GO:0006400 | tRNA modification(GO:0006400) |
0.1 | 0.1 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.1 | 0.1 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.1 | 0.1 | GO:0035357 | peroxisome proliferator activated receptor signaling pathway(GO:0035357) |
0.1 | 0.1 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.1 | 0.1 | GO:2000224 | regulation of testosterone biosynthetic process(GO:2000224) |
0.1 | 0.1 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.1 | 0.2 | GO:0090224 | regulation of spindle organization(GO:0090224) |
0.1 | 0.1 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.1 | 0.5 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.1 | 1.1 | GO:0043113 | receptor clustering(GO:0043113) |
0.1 | 2.7 | GO:0008033 | tRNA processing(GO:0008033) |
0.1 | 0.2 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.1 | 0.1 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.1 | 0.2 | GO:0031639 | plasminogen activation(GO:0031639) |
0.1 | 0.2 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.1 | 0.1 | GO:1903055 | positive regulation of extracellular matrix organization(GO:1903055) |
0.1 | 0.2 | GO:0060022 | hard palate development(GO:0060022) |
0.1 | 0.7 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.1 | 0.6 | GO:0010737 | protein kinase A signaling(GO:0010737) |
0.1 | 0.3 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.1 | 0.3 | GO:0019240 | citrulline biosynthetic process(GO:0019240) |
0.1 | 0.1 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.1 | 0.2 | GO:1900118 | negative regulation of execution phase of apoptosis(GO:1900118) |
0.1 | 0.2 | GO:0045953 | negative regulation of natural killer cell mediated cytotoxicity(GO:0045953) |
0.1 | 0.2 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.1 | 0.1 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.1 | 0.3 | GO:0031629 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.1 | 0.2 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
0.1 | 0.1 | GO:0060920 | cardiac pacemaker cell differentiation(GO:0060920) |
0.1 | 0.2 | GO:0032392 | DNA geometric change(GO:0032392) |
0.1 | 0.1 | GO:0001805 | type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
0.1 | 0.7 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 0.2 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.1 | 0.2 | GO:0019346 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
0.1 | 0.1 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
0.1 | 0.2 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.1 | 0.1 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.1 | 0.1 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.1 | 0.1 | GO:0034661 | ncRNA catabolic process(GO:0034661) |
0.1 | 0.1 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.1 | 0.1 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.1 | 0.1 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.1 | 0.2 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.1 | 0.1 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.1 | 0.1 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.1 | 0.1 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
0.1 | 0.1 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.1 | 0.8 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.1 | 0.1 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.1 | 0.4 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.1 | 1.0 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.1 | 0.1 | GO:0021779 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.1 | 0.5 | GO:0000154 | rRNA modification(GO:0000154) |
0.1 | 0.1 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.1 | 0.1 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.1 | 0.1 | GO:2000269 | regulation of fibroblast apoptotic process(GO:2000269) |
0.1 | 0.7 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.1 | 0.1 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.1 | 0.6 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.1 | 0.1 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.1 | 1.0 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.1 | 0.1 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.1 | 0.1 | GO:0015781 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.1 | 0.1 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.1 | 0.3 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
0.1 | 0.1 | GO:1990000 | amyloid fibril formation(GO:1990000) |
0.1 | 0.1 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.0 | 0.3 | GO:1902108 | regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902108) |
0.0 | 0.8 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.0 | 0.0 | GO:0042402 | cellular biogenic amine catabolic process(GO:0042402) |
0.0 | 0.0 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.0 | 0.0 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.0 | 0.3 | GO:0002551 | mast cell chemotaxis(GO:0002551) |
0.0 | 0.2 | GO:0042711 | maternal behavior(GO:0042711) |
0.0 | 0.6 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.0 | 0.2 | GO:2001204 | regulation of osteoclast development(GO:2001204) |
0.0 | 0.7 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
0.0 | 0.1 | GO:0006110 | regulation of glycolytic process(GO:0006110) |
0.0 | 0.2 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.0 | 0.1 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.0 | 0.0 | GO:0030299 | intestinal cholesterol absorption(GO:0030299) |
0.0 | 2.7 | GO:0019941 | modification-dependent protein catabolic process(GO:0019941) |
0.0 | 0.8 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.0 | 0.1 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.0 | 0.1 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.0 | 0.5 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.0 | 1.1 | GO:0050852 | T cell receptor signaling pathway(GO:0050852) |
0.0 | 0.3 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.0 | 0.1 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.0 | 0.2 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.0 | 0.0 | GO:1902075 | cellular response to salt(GO:1902075) |
0.0 | 0.5 | GO:0045047 | protein targeting to ER(GO:0045047) establishment of protein localization to endoplasmic reticulum(GO:0072599) |
0.0 | 0.1 | GO:0042701 | progesterone secretion(GO:0042701) |
0.0 | 0.0 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.0 | 0.2 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.0 | 0.0 | GO:0060956 | endocardial cell differentiation(GO:0060956) |
0.0 | 0.3 | GO:0071347 | cellular response to interleukin-1(GO:0071347) |
0.0 | 0.0 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.0 | 0.2 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.0 | 0.0 | GO:0003284 | septum primum development(GO:0003284) atrial septum primum morphogenesis(GO:0003289) |
0.0 | 0.4 | GO:0051057 | positive regulation of small GTPase mediated signal transduction(GO:0051057) |
0.0 | 0.3 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.0 | 0.2 | GO:0010889 | regulation of sequestering of triglyceride(GO:0010889) |
0.0 | 0.1 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
0.0 | 1.0 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
0.0 | 0.2 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.0 | 0.9 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.0 | 0.0 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) positive regulation of hh target transcription factor activity(GO:0007228) |
0.0 | 0.1 | GO:1901298 | regulation of hydrogen peroxide-mediated programmed cell death(GO:1901298) |
0.0 | 1.1 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.0 | 0.4 | GO:0070265 | necrotic cell death(GO:0070265) |
0.0 | 0.0 | GO:0051181 | cofactor transport(GO:0051181) |
0.0 | 0.0 | GO:0072008 | glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
0.0 | 0.1 | GO:0000726 | non-recombinational repair(GO:0000726) |
0.0 | 0.0 | GO:0044088 | regulation of vacuole organization(GO:0044088) |
0.0 | 0.1 | GO:0032536 | regulation of cell projection size(GO:0032536) |
0.0 | 0.1 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.0 | 0.1 | GO:0034434 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.0 | 0.4 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.0 | 3.0 | GO:0010498 | proteasomal protein catabolic process(GO:0010498) |
0.0 | 0.2 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.0 | 1.5 | GO:0006865 | amino acid transport(GO:0006865) |
0.0 | 0.0 | GO:0010042 | response to manganese ion(GO:0010042) |
0.0 | 0.1 | GO:0097012 | response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.0 | 0.1 | GO:0007619 | courtship behavior(GO:0007619) female courtship behavior(GO:0008050) |
0.0 | 0.2 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.0 | 0.0 | GO:0015677 | copper ion import(GO:0015677) |
0.0 | 0.0 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.0 | 0.0 | GO:0001768 | establishment of lymphocyte polarity(GO:0001767) establishment of T cell polarity(GO:0001768) |
0.0 | 0.0 | GO:0044839 | cell cycle G2/M phase transition(GO:0044839) |
0.0 | 0.0 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.0 | 0.6 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
0.0 | 0.3 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.0 | 0.0 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
0.0 | 0.1 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.0 | 0.1 | GO:1902808 | positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.0 | 0.7 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.0 | 0.0 | GO:0060117 | auditory receptor cell development(GO:0060117) |
0.0 | 0.6 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.0 | 0.1 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.0 | 1.9 | GO:0051168 | nuclear export(GO:0051168) |
0.0 | 0.1 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.0 | 0.1 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.0 | 0.2 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.0 | 0.1 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.0 | 0.1 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.0 | 0.0 | GO:0070417 | cellular response to cold(GO:0070417) |
0.0 | 0.0 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.0 | 0.1 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.0 | 0.1 | GO:0042435 | indole-containing compound biosynthetic process(GO:0042435) |
0.0 | 0.2 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
0.0 | 0.7 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.0 | 0.2 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.0 | 0.2 | GO:1990748 | cellular oxidant detoxification(GO:0098869) cellular detoxification(GO:1990748) |
0.0 | 0.4 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.0 | 0.1 | GO:0010390 | histone monoubiquitination(GO:0010390) |
0.0 | 0.2 | GO:0042640 | anagen(GO:0042640) |
0.0 | 0.1 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.0 | 0.3 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.0 | 0.0 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.0 | 0.3 | GO:1903206 | negative regulation of hydrogen peroxide-induced cell death(GO:1903206) |
0.0 | 0.0 | GO:0046544 | development of secondary male sexual characteristics(GO:0046544) |
0.0 | 0.4 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.0 | 0.5 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.0 | 0.0 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
0.0 | 0.1 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.0 | 0.2 | GO:0044821 | telomere tethering at nuclear periphery(GO:0034398) meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.0 | 0.0 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.0 | 0.1 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.0 | 0.3 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
0.0 | 0.2 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.0 | 0.6 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.0 | 0.1 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.0 | 0.4 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.0 | 0.9 | GO:0007030 | Golgi organization(GO:0007030) |
0.0 | 0.0 | GO:0018343 | protein farnesylation(GO:0018343) |
0.0 | 0.2 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.0 | 0.1 | GO:0033574 | response to testosterone(GO:0033574) |
0.0 | 0.1 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.0 | 0.2 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.0 | 0.1 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
0.0 | 0.3 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.0 | 0.1 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.0 | 0.0 | GO:0070849 | response to epidermal growth factor(GO:0070849) cellular response to epidermal growth factor stimulus(GO:0071364) |
0.0 | 0.6 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.0 | 0.2 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.0 | 0.0 | GO:0017014 | protein nitrosylation(GO:0017014) |
0.0 | 0.1 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.0 | 0.0 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.0 | 0.1 | GO:0098764 | meiotic prophase I(GO:0007128) prophase(GO:0051324) meiotic cell cycle phase(GO:0098762) meiosis I cell cycle phase(GO:0098764) |
0.0 | 0.2 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.0 | 0.1 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.0 | 0.0 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.0 | 0.0 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.0 | 0.1 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.0 | 0.1 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.0 | 0.3 | GO:0006818 | hydrogen transport(GO:0006818) |
0.0 | 0.1 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.0 | 0.0 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.0 | 0.1 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
0.0 | 0.1 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.0 | 0.1 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.0 | 0.6 | GO:0006101 | citrate metabolic process(GO:0006101) |
0.0 | 0.1 | GO:0015747 | urate transport(GO:0015747) |
0.0 | 0.1 | GO:0002431 | Fc receptor mediated stimulatory signaling pathway(GO:0002431) |
0.0 | 0.0 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.0 | 0.1 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.0 | 0.0 | GO:0031446 | regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
0.0 | 0.0 | GO:2000515 | negative regulation of CD4-positive, alpha-beta T cell activation(GO:2000515) |
0.0 | 0.1 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.0 | 0.1 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.0 | 0.0 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.1 | GO:0001710 | mesodermal cell fate commitment(GO:0001710) |
0.0 | 0.1 | GO:0006265 | DNA topological change(GO:0006265) |
0.0 | 0.0 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.0 | 0.0 | GO:0002220 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) |
0.0 | 0.0 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.0 | 0.1 | GO:2000406 | positive regulation of T cell migration(GO:2000406) |
0.0 | 0.3 | GO:0007031 | peroxisome organization(GO:0007031) |
0.0 | 0.6 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.0 | 0.1 | GO:0006399 | tRNA metabolic process(GO:0006399) |
0.0 | 0.1 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.0 | 0.2 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.0 | 0.2 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.0 | 0.1 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.0 | 0.1 | GO:0060631 | regulation of meiosis I(GO:0060631) |
0.0 | 0.1 | GO:0009113 | purine nucleobase biosynthetic process(GO:0009113) |
0.0 | 0.4 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 0.0 | GO:0034032 | nucleoside bisphosphate metabolic process(GO:0033865) ribonucleoside bisphosphate metabolic process(GO:0033875) purine nucleoside bisphosphate metabolic process(GO:0034032) |
0.0 | 0.5 | GO:0051297 | centrosome organization(GO:0051297) |
0.0 | 0.0 | GO:0034145 | positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
0.0 | 0.1 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.0 | 0.2 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.0 | 2.2 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.0 | 0.1 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.0 | 0.1 | GO:0070861 | regulation of protein exit from endoplasmic reticulum(GO:0070861) |
0.0 | 0.1 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.0 | 0.1 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.1 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
0.0 | 0.0 | GO:1904429 | regulation of t-circle formation(GO:1904429) |
0.0 | 0.1 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.0 | 0.1 | GO:0035425 | autocrine signaling(GO:0035425) |
0.0 | 0.1 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.0 | 0.3 | GO:0030641 | regulation of cellular pH(GO:0030641) |
0.0 | 1.1 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.0 | 0.0 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
0.0 | 0.0 | GO:0098787 | mRNA cleavage involved in mRNA processing(GO:0098787) |
0.0 | 0.0 | GO:0032740 | positive regulation of interleukin-17 production(GO:0032740) |
0.0 | 0.0 | GO:0042987 | amyloid precursor protein catabolic process(GO:0042987) |
0.0 | 0.1 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
0.0 | 0.1 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.0 | 0.2 | GO:0036065 | fucosylation(GO:0036065) |
0.0 | 0.1 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
0.0 | 0.7 | GO:0050657 | nucleic acid transport(GO:0050657) RNA transport(GO:0050658) |
0.0 | 0.1 | GO:0046950 | cellular ketone body metabolic process(GO:0046950) |
0.0 | 0.0 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.0 | 0.1 | GO:0032094 | response to food(GO:0032094) |
0.0 | 0.0 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.0 | 0.0 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.0 | 0.1 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.0 | 0.0 | GO:0035865 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.0 | 0.1 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.0 | 0.1 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.0 | 0.2 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.0 | 0.0 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.0 | 0.4 | GO:0006953 | acute-phase response(GO:0006953) |
0.0 | 0.1 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.0 | 0.2 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.0 | 0.0 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.0 | 0.7 | GO:0000910 | cytokinesis(GO:0000910) |
0.0 | 0.0 | GO:0014742 | positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
0.0 | 0.2 | GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
0.0 | 0.0 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.0 | 0.1 | GO:0048302 | isotype switching to IgG isotypes(GO:0048291) regulation of isotype switching to IgG isotypes(GO:0048302) |
0.0 | 0.7 | GO:0050821 | protein stabilization(GO:0050821) |
0.0 | 0.0 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.0 | 0.1 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.0 | 0.0 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.0 | 0.1 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.0 | 0.0 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.0 | 0.0 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.0 | 0.0 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.0 | 0.1 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.0 | 0.0 | GO:0090049 | regulation of cell migration involved in sprouting angiogenesis(GO:0090049) |
0.0 | 0.0 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.0 | 1.3 | GO:0015711 | organic anion transport(GO:0015711) |
0.0 | 0.0 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.0 | 0.0 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.0 | 0.1 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.0 | 0.0 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
0.0 | 0.0 | GO:0072126 | positive regulation of glomerular mesangial cell proliferation(GO:0072126) |
0.0 | 0.0 | GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway(GO:0031664) |
0.0 | 0.0 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.0 | 0.1 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.0 | 0.0 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
0.0 | 0.0 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.0 | 0.0 | GO:0010965 | regulation of mitotic sister chromatid separation(GO:0010965) |
0.0 | 0.0 | GO:0009445 | putrescine metabolic process(GO:0009445) |
0.0 | 0.0 | GO:0051934 | dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) |
0.0 | 0.2 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.0 | 0.0 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.0 | 0.2 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.0 | 0.0 | GO:0042537 | benzene-containing compound metabolic process(GO:0042537) |
0.0 | 0.3 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.0 | 0.0 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
0.0 | 0.1 | GO:0002717 | positive regulation of natural killer cell mediated immunity(GO:0002717) positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.0 | 0.1 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.0 | 0.0 | GO:0034138 | toll-like receptor 3 signaling pathway(GO:0034138) |
0.0 | 0.1 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.0 | 0.0 | GO:0015918 | sterol transport(GO:0015918) |
0.0 | 0.6 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.0 | GO:0002407 | dendritic cell chemotaxis(GO:0002407) |
0.0 | 0.0 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.0 | 0.2 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.0 | 0.0 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.0 | 0.0 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.0 | 0.0 | GO:0002484 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.0 | 0.1 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.0 | 0.1 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.0 | 0.1 | GO:0032965 | regulation of collagen biosynthetic process(GO:0032965) |
0.0 | 0.3 | GO:0071466 | cellular response to xenobiotic stimulus(GO:0071466) |
0.0 | 0.0 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.0 | 0.0 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.0 | 0.1 | GO:0019098 | reproductive behavior(GO:0019098) |
0.0 | 0.1 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.0 | 0.0 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.0 | 0.0 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) |
0.0 | 0.0 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.0 | 0.0 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.0 | 0.0 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.0 | 0.0 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.0 | 0.0 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.0 | 0.0 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.0 | 0.1 | GO:0032098 | regulation of appetite(GO:0032098) |
0.0 | 0.0 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.0 | 0.0 | GO:0060535 | trachea cartilage morphogenesis(GO:0060535) |
0.0 | 0.0 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.0 | 0.1 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.0 | 0.0 | GO:0036474 | cell death in response to hydrogen peroxide(GO:0036474) |
0.0 | 0.0 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.0 | 0.1 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.0 | 0.0 | GO:0033762 | response to glucagon(GO:0033762) |
0.0 | 0.0 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.0 | 0.0 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.0 | 0.1 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.0 | 0.0 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.0 | 0.0 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.0 | 0.0 | GO:0051882 | mitochondrial depolarization(GO:0051882) |
0.0 | 0.5 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
0.0 | 1.2 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.0 | GO:0070091 | glucagon secretion(GO:0070091) |
0.0 | 0.0 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) |
0.0 | 0.0 | GO:0071554 | cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.0 | 0.2 | GO:0001541 | ovarian follicle development(GO:0001541) |
0.0 | 0.0 | GO:0048069 | eye pigmentation(GO:0048069) |
0.0 | 0.0 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
0.0 | 0.0 | GO:0002215 | defense response to nematode(GO:0002215) |
0.0 | 0.1 | GO:0002347 | response to tumor cell(GO:0002347) |
0.0 | 0.0 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
0.0 | 0.1 | GO:0002902 | regulation of B cell apoptotic process(GO:0002902) |
0.0 | 0.0 | GO:0042026 | protein refolding(GO:0042026) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 4.2 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
1.0 | 6.0 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.8 | 3.3 | GO:0098536 | deuterosome(GO:0098536) |
0.8 | 2.4 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.8 | 4.6 | GO:0005796 | Golgi lumen(GO:0005796) |
0.7 | 2.9 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.7 | 6.7 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.7 | 2.7 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.7 | 2.0 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.6 | 6.3 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.6 | 2.5 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.6 | 3.1 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.6 | 1.8 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.6 | 4.1 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.6 | 1.7 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.6 | 5.7 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.6 | 2.3 | GO:0005642 | annulate lamellae(GO:0005642) |
0.6 | 2.8 | GO:0097433 | dense body(GO:0097433) |
0.6 | 2.8 | GO:0061617 | MICOS complex(GO:0061617) |
0.5 | 2.2 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.5 | 1.4 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.5 | 3.3 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.5 | 2.8 | GO:0071986 | Ragulator complex(GO:0071986) |
0.5 | 3.2 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.4 | 1.3 | GO:0044393 | microspike(GO:0044393) |
0.4 | 1.7 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.4 | 1.6 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.4 | 4.9 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.4 | 0.8 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.4 | 3.2 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.4 | 1.6 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.4 | 1.2 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.4 | 3.1 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.4 | 1.9 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.4 | 1.2 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.4 | 3.8 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.4 | 1.1 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.4 | 1.1 | GO:0070876 | SOSS complex(GO:0070876) |
0.4 | 0.4 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.4 | 2.2 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.4 | 1.5 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.4 | 1.5 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.4 | 1.5 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.4 | 1.4 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.4 | 1.4 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.3 | 1.0 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.3 | 4.1 | GO:0044292 | dendrite terminus(GO:0044292) |
0.3 | 9.1 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.3 | 3.0 | GO:0060091 | kinocilium(GO:0060091) |
0.3 | 0.7 | GO:0016469 | proton-transporting two-sector ATPase complex(GO:0016469) |
0.3 | 1.0 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.3 | 1.3 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.3 | 1.0 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.3 | 1.6 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.3 | 3.8 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.3 | 5.0 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.3 | 2.2 | GO:0070187 | telosome(GO:0070187) |
0.3 | 2.5 | GO:0042627 | chylomicron(GO:0042627) |
0.3 | 0.9 | GO:0071797 | LUBAC complex(GO:0071797) |
0.3 | 1.8 | GO:0061700 | Seh1-associated complex(GO:0035859) GATOR2 complex(GO:0061700) |
0.3 | 2.4 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.3 | 3.2 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.3 | 1.4 | GO:0045252 | dihydrolipoyl dehydrogenase complex(GO:0045240) oxoglutarate dehydrogenase complex(GO:0045252) |
0.3 | 0.6 | GO:0030894 | replisome(GO:0030894) |
0.3 | 0.9 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.3 | 3.9 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.3 | 0.8 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.3 | 1.1 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.3 | 1.4 | GO:0097422 | tubular endosome(GO:0097422) |
0.3 | 3.4 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.3 | 7.2 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.3 | 1.1 | GO:0035339 | SPOTS complex(GO:0035339) |
0.3 | 2.7 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.3 | 0.8 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.3 | 1.3 | GO:0005638 | lamin filament(GO:0005638) |
0.3 | 1.1 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.3 | 2.1 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.3 | 1.0 | GO:1990246 | uniplex complex(GO:1990246) |
0.3 | 1.5 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.3 | 3.8 | GO:0097440 | apical dendrite(GO:0097440) |
0.3 | 1.3 | GO:0000235 | astral microtubule(GO:0000235) |
0.2 | 2.0 | GO:0008278 | cohesin complex(GO:0008278) |
0.2 | 3.5 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.2 | 2.2 | GO:0005883 | neurofilament(GO:0005883) |
0.2 | 0.7 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.2 | 0.7 | GO:0000811 | GINS complex(GO:0000811) |
0.2 | 3.6 | GO:0000242 | pericentriolar material(GO:0000242) |
0.2 | 0.7 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.2 | 0.7 | GO:0005712 | chiasma(GO:0005712) |
0.2 | 0.9 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.2 | 1.4 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.2 | 2.1 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 3.9 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.2 | 0.9 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.2 | 0.7 | GO:0000125 | PCAF complex(GO:0000125) |
0.2 | 1.1 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.2 | 1.8 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.2 | 0.2 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.2 | 1.1 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.2 | 3.4 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.2 | 1.3 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.2 | 0.2 | GO:0031088 | platelet dense granule membrane(GO:0031088) platelet dense granule(GO:0042827) |
0.2 | 0.4 | GO:0031523 | Myb complex(GO:0031523) |
0.2 | 2.4 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.2 | 1.3 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.2 | 3.0 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.2 | 1.3 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.2 | 1.3 | GO:0031415 | NatA complex(GO:0031415) |
0.2 | 4.1 | GO:0097228 | sperm principal piece(GO:0097228) |
0.2 | 3.0 | GO:0071565 | nBAF complex(GO:0071565) |
0.2 | 0.6 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.2 | 8.9 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.2 | 1.1 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.2 | 7.2 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.2 | 1.2 | GO:0034464 | BBSome(GO:0034464) |
0.2 | 0.4 | GO:0005955 | calcineurin complex(GO:0005955) |
0.2 | 1.4 | GO:0097449 | astrocyte projection(GO:0097449) |
0.2 | 2.2 | GO:0032039 | integrator complex(GO:0032039) |
0.2 | 2.4 | GO:0033646 | host cell cytoplasm(GO:0030430) host intracellular part(GO:0033646) host cell cytoplasm part(GO:0033655) intracellular region of host(GO:0043656) |
0.2 | 0.8 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.2 | 0.6 | GO:0044462 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.2 | 0.6 | GO:0070852 | cell body fiber(GO:0070852) |
0.2 | 1.3 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.2 | 0.4 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.2 | 1.1 | GO:0016600 | flotillin complex(GO:0016600) |
0.2 | 0.9 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.2 | 0.4 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.2 | 0.4 | GO:0000779 | condensed chromosome, centromeric region(GO:0000779) |
0.2 | 1.1 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.2 | 1.3 | GO:0016272 | prefoldin complex(GO:0016272) |
0.2 | 0.2 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.2 | 0.2 | GO:0019867 | outer membrane(GO:0019867) |
0.2 | 0.2 | GO:0070069 | cytochrome complex(GO:0070069) |
0.2 | 0.7 | GO:0035363 | histone locus body(GO:0035363) |
0.2 | 3.3 | GO:0031082 | BLOC complex(GO:0031082) |
0.2 | 0.5 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.2 | 0.4 | GO:0005657 | replication fork(GO:0005657) |
0.2 | 0.5 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.2 | 0.7 | GO:0097452 | GAIT complex(GO:0097452) |
0.2 | 0.5 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.2 | 0.4 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.2 | 0.5 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.2 | 0.3 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.2 | 1.2 | GO:0031209 | SCAR complex(GO:0031209) |
0.2 | 2.3 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.2 | 0.7 | GO:1990130 | Iml1 complex(GO:1990130) |
0.2 | 0.3 | GO:0005683 | U7 snRNP(GO:0005683) |
0.2 | 4.6 | GO:0015030 | Cajal body(GO:0015030) |
0.2 | 4.9 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.2 | 0.5 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.2 | 0.7 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.2 | 0.5 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.2 | 0.6 | GO:0071203 | WASH complex(GO:0071203) |
0.2 | 0.3 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.2 | 2.7 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.2 | 0.3 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.2 | 0.3 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.2 | 0.6 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
0.2 | 1.9 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.2 | 0.8 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.2 | 1.1 | GO:0033263 | CORVET complex(GO:0033263) |
0.2 | 0.5 | GO:0043203 | axon hillock(GO:0043203) |
0.2 | 6.1 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.2 | 3.5 | GO:0035861 | site of double-strand break(GO:0035861) |
0.2 | 5.3 | GO:0016592 | mediator complex(GO:0016592) |
0.2 | 0.5 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.2 | 1.1 | GO:0001939 | female pronucleus(GO:0001939) |
0.2 | 1.5 | GO:0022624 | proteasome accessory complex(GO:0022624) |
0.1 | 0.6 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.1 | 0.1 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 0.4 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.1 | 0.9 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 6.3 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.1 | 0.1 | GO:0033010 | paranodal junction(GO:0033010) |
0.1 | 0.3 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.1 | 1.7 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 1.4 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.1 | 0.3 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.1 | 0.4 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.1 | 0.4 | GO:0097413 | Lewy body(GO:0097413) |
0.1 | 1.2 | GO:0010369 | chromocenter(GO:0010369) |
0.1 | 4.1 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.1 | 1.3 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 1.2 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.1 | 0.4 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 3.5 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 10.1 | GO:0000776 | kinetochore(GO:0000776) |
0.1 | 4.2 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.1 | 2.1 | GO:0005682 | U5 snRNP(GO:0005682) |
0.1 | 0.9 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.1 | 0.3 | GO:0070469 | respiratory chain(GO:0070469) |
0.1 | 0.3 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.1 | 1.7 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.1 | 0.3 | GO:0002177 | manchette(GO:0002177) |
0.1 | 0.6 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.1 | 0.2 | GO:0005767 | secondary lysosome(GO:0005767) |
0.1 | 15.1 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 10.8 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.1 | 0.5 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.1 | 4.6 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.1 | 29.4 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.1 | 0.5 | GO:0016363 | nuclear matrix(GO:0016363) |
0.1 | 0.5 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.1 | 0.4 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.1 | 0.6 | GO:0005579 | membrane attack complex(GO:0005579) |
0.1 | 0.1 | GO:0046930 | pore complex(GO:0046930) |
0.1 | 1.8 | GO:0098573 | intrinsic component of mitochondrial membrane(GO:0098573) |
0.1 | 1.7 | GO:0031011 | Ino80 complex(GO:0031011) |
0.1 | 0.5 | GO:0000805 | X chromosome(GO:0000805) |
0.1 | 1.7 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.1 | 1.9 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 0.3 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.1 | 2.1 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 0.5 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.1 | 0.9 | GO:0030914 | STAGA complex(GO:0030914) |
0.1 | 0.5 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 1.9 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 1.1 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.1 | 0.7 | GO:1990391 | DNA repair complex(GO:1990391) |
0.1 | 1.0 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 0.6 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.1 | 6.5 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 2.3 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.1 | 0.4 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.1 | 1.6 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.1 | 0.9 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 0.4 | GO:0033269 | internode region of axon(GO:0033269) |
0.1 | 0.2 | GO:0097346 | INO80-type complex(GO:0097346) |
0.1 | 0.3 | GO:0032280 | symmetric synapse(GO:0032280) |
0.1 | 0.3 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 0.2 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 0.5 | GO:0030135 | coated vesicle(GO:0030135) |
0.1 | 0.3 | GO:0055087 | Ski complex(GO:0055087) |
0.1 | 1.0 | GO:0070938 | contractile ring(GO:0070938) |
0.1 | 1.7 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 0.1 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 0.8 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 2.7 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.1 | 0.2 | GO:0000322 | storage vacuole(GO:0000322) |
0.1 | 0.1 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.1 | 0.7 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.1 | 5.6 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.1 | 0.9 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 5.1 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 3.0 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 0.1 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.1 | 2.5 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.1 | 0.2 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.1 | 0.6 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.1 | 0.5 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.1 | 1.2 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 0.6 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.1 | 6.0 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.1 | 2.3 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.1 | 5.7 | GO:0005840 | ribosome(GO:0005840) |
0.1 | 0.3 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.1 | 0.6 | GO:0030677 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.1 | 0.5 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 0.2 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.1 | 0.7 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.1 | 0.6 | GO:0031931 | TORC1 complex(GO:0031931) |
0.1 | 0.2 | GO:0030990 | intraciliary transport particle(GO:0030990) |
0.1 | 1.2 | GO:0044295 | axonal growth cone(GO:0044295) |
0.1 | 0.4 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 0.8 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.1 | 0.3 | GO:0070820 | tertiary granule(GO:0070820) |
0.1 | 6.0 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.1 | 0.2 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.1 | 0.1 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.1 | 0.1 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.1 | 0.8 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 0.3 | GO:0030689 | Noc complex(GO:0030689) |
0.1 | 0.2 | GO:0072534 | perineuronal net(GO:0072534) |
0.1 | 0.3 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.1 | 0.6 | GO:0001650 | fibrillar center(GO:0001650) |
0.1 | 6.1 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 0.4 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.1 | 0.3 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.1 | 0.7 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.1 | 3.6 | GO:0015630 | microtubule cytoskeleton(GO:0015630) |
0.1 | 0.1 | GO:0061574 | ASAP complex(GO:0061574) |
0.1 | 1.4 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 0.1 | GO:0051286 | cell tip(GO:0051286) |
0.1 | 0.3 | GO:0000796 | condensin complex(GO:0000796) |
0.1 | 0.2 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.1 | 0.4 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 2.1 | GO:0000793 | condensed chromosome(GO:0000793) |
0.1 | 0.2 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.1 | 0.1 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.1 | 0.2 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 0.5 | GO:0034719 | SMN complex(GO:0032797) SMN-Sm protein complex(GO:0034719) |
0.1 | 0.8 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.1 | 1.8 | GO:0044853 | caveola(GO:0005901) plasma membrane raft(GO:0044853) |
0.1 | 0.7 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.1 | 8.0 | GO:0000139 | Golgi membrane(GO:0000139) |
0.1 | 3.3 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 1.2 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.1 | 0.6 | GO:0005685 | U1 snRNP(GO:0005685) |
0.1 | 3.4 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.1 | 0.1 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.1 | 0.2 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.1 | 0.1 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.1 | 0.2 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 3.1 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 0.7 | GO:0005839 | proteasome core complex(GO:0005839) |
0.1 | 0.5 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.1 | 1.0 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.1 | 0.1 | GO:0097526 | spliceosomal tri-snRNP complex(GO:0097526) |
0.1 | 0.1 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.1 | 0.3 | GO:0032009 | early phagosome(GO:0032009) |
0.1 | 0.3 | GO:0051233 | spindle midzone(GO:0051233) |
0.1 | 6.4 | GO:0031965 | nuclear membrane(GO:0031965) |
0.1 | 3.2 | GO:0030427 | site of polarized growth(GO:0030427) |
0.1 | 5.0 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.1 | 0.7 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 52.7 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 0.5 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 0.7 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.1 | 0.5 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.1 | 0.1 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 0.2 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.1 | 0.9 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.1 | 1.0 | GO:0000502 | proteasome complex(GO:0000502) |
0.1 | 1.2 | GO:0005875 | microtubule associated complex(GO:0005875) |
0.1 | 0.2 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 0.2 | GO:0031417 | NatC complex(GO:0031417) |
0.1 | 6.5 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 0.3 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.1 | 1.5 | GO:0043204 | perikaryon(GO:0043204) |
0.1 | 0.7 | GO:0000792 | heterochromatin(GO:0000792) |
0.1 | 1.0 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 0.2 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.1 | 0.2 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.1 | 0.4 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.1 | 0.5 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 0.1 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.1 | 0.9 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.1 | 1.5 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.1 | 1.9 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.1 | 1.0 | GO:0032040 | small-subunit processome(GO:0032040) |
0.1 | 0.1 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.1 | 12.1 | GO:0005813 | centrosome(GO:0005813) |
0.1 | 0.7 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.0 | 1.0 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.0 | 0.0 | GO:0043073 | germ cell nucleus(GO:0043073) |
0.0 | 2.9 | GO:0031975 | envelope(GO:0031975) |
0.0 | 0.2 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.0 | 15.5 | GO:0005730 | nucleolus(GO:0005730) |
0.0 | 0.0 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.0 | 0.1 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.0 | 1.8 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 0.0 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.0 | 0.7 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.0 | 0.4 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 0.9 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 0.3 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.0 | 0.1 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.0 | 0.2 | GO:0030904 | retromer complex(GO:0030904) |
0.0 | 0.2 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.0 | 0.4 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 0.1 | GO:0071817 | MMXD complex(GO:0071817) |
0.0 | 0.2 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 0.6 | GO:0043034 | costamere(GO:0043034) |
0.0 | 0.0 | GO:0071564 | npBAF complex(GO:0071564) |
0.0 | 0.0 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.0 | 0.1 | GO:0097255 | R2TP complex(GO:0097255) |
0.0 | 0.3 | GO:0031301 | integral component of organelle membrane(GO:0031301) |
0.0 | 0.2 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 27.2 | GO:0005829 | cytosol(GO:0005829) |
0.0 | 0.4 | GO:0001891 | phagocytic cup(GO:0001891) |
0.0 | 0.2 | GO:0032426 | stereocilium tip(GO:0032426) |
0.0 | 0.1 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.0 | 0.0 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 0.3 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.0 | 0.2 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.0 | 0.1 | GO:0090543 | Flemming body(GO:0090543) |
0.0 | 6.2 | GO:0005874 | microtubule(GO:0005874) |
0.0 | 0.3 | GO:0043194 | axon initial segment(GO:0043194) |
0.0 | 0.1 | GO:0042555 | MCM complex(GO:0042555) |
0.0 | 0.5 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.4 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 0.2 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.0 | 2.2 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 0.0 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.0 | 0.2 | GO:0005771 | multivesicular body(GO:0005771) |
0.0 | 0.1 | GO:0043511 | inhibin complex(GO:0043511) |
0.0 | 0.2 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.0 | 0.4 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.1 | GO:0042599 | lamellar body(GO:0042599) |
0.0 | 7.0 | GO:0005773 | vacuole(GO:0005773) |
0.0 | 0.1 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.1 | GO:0005795 | Golgi stack(GO:0005795) |
0.0 | 0.2 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.0 | 0.1 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.0 | 0.1 | GO:1990923 | PET complex(GO:1990923) |
0.0 | 0.2 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.0 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.0 | 0.1 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.0 | 9.1 | GO:0005794 | Golgi apparatus(GO:0005794) |
0.0 | 16.0 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 2.3 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.6 | GO:0005884 | actin filament(GO:0005884) |
0.0 | 0.2 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 0.0 | GO:0034704 | calcium channel complex(GO:0034704) |
0.0 | 0.0 | GO:0072686 | mitotic spindle(GO:0072686) |
0.0 | 12.6 | GO:0005654 | nucleoplasm(GO:0005654) |
0.0 | 0.2 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.0 | 0.0 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.0 | 0.0 | GO:0030686 | 90S preribosome(GO:0030686) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 6.9 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
1.5 | 4.6 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
1.4 | 4.1 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
1.4 | 4.1 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
1.3 | 1.3 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
1.3 | 3.9 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
1.3 | 3.8 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
1.2 | 4.7 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
1.1 | 8.9 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
1.1 | 4.3 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.9 | 2.8 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.9 | 2.7 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.9 | 2.7 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.9 | 3.5 | GO:0043515 | kinetochore binding(GO:0043515) |
0.9 | 1.7 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.9 | 2.6 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.8 | 2.5 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.8 | 3.2 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.8 | 3.2 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.8 | 8.4 | GO:0052673 | cobinamide kinase activity(GO:0008819) phytol kinase activity(GO:0010276) phenol kinase activity(GO:0018720) cyclin-dependent protein kinase activating kinase regulator activity(GO:0019914) inositol tetrakisphosphate 2-kinase activity(GO:0032942) heptose 7-phosphate kinase activity(GO:0033785) aminoglycoside phosphotransferase activity(GO:0034071) eukaryotic elongation factor-2 kinase regulator activity(GO:0042556) eukaryotic elongation factor-2 kinase activator activity(GO:0042557) LPPG:FO 2-phospho-L-lactate transferase activity(GO:0043743) cytidine kinase activity(GO:0043771) glycerate 2-kinase activity(GO:0043798) (S)-lactate 2-kinase activity(GO:0043841) phosphoserine:homoserine phosphotransferase activity(GO:0043899) L-seryl-tRNA(Sec) kinase activity(GO:0043915) phosphocholine transferase activity(GO:0044605) GTP-dependent polynucleotide kinase activity(GO:0051735) farnesol kinase activity(GO:0052668) CTP:2-trans,-6-trans-farnesol kinase activity(GO:0052669) geraniol kinase activity(GO:0052670) geranylgeraniol kinase activity(GO:0052671) CTP:geranylgeraniol kinase activity(GO:0052672) prenol kinase activity(GO:0052673) 1-phosphatidylinositol-5-kinase activity(GO:0052810) 1-phosphatidylinositol-3-phosphate 4-kinase activity(GO:0052811) phosphatidylinositol-3,4-bisphosphate 5-kinase activity(GO:0052812) inositol-3,4,6-trisphosphate 1-kinase activity(GO:0052835) inositol 5-diphosphate pentakisphosphate 5-kinase activity(GO:0052836) inositol diphosphate tetrakisphosphate kinase activity(GO:0052839) |
0.8 | 5.3 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.7 | 3.7 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.7 | 2.2 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.7 | 2.8 | GO:0050693 | LBD domain binding(GO:0050693) |
0.7 | 4.3 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.7 | 4.8 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.7 | 4.1 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.7 | 2.0 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.7 | 1.3 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.6 | 5.8 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.6 | 2.6 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.6 | 1.9 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.6 | 3.2 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.6 | 7.5 | GO:0043176 | amine binding(GO:0043176) |
0.6 | 1.9 | GO:0015205 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.6 | 3.7 | GO:0035473 | lipase binding(GO:0035473) |
0.6 | 1.9 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.6 | 3.1 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.6 | 3.6 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.6 | 2.4 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.6 | 4.2 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.6 | 3.0 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.6 | 1.8 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.6 | 1.7 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.6 | 2.8 | GO:0070061 | fructose binding(GO:0070061) |
0.5 | 2.7 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) |
0.5 | 3.2 | GO:0016151 | nickel cation binding(GO:0016151) |
0.5 | 2.1 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.5 | 1.0 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
0.5 | 5.6 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.5 | 0.5 | GO:0032142 | single guanine insertion binding(GO:0032142) |
0.5 | 4.0 | GO:0001164 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.5 | 1.0 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
0.5 | 1.9 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.5 | 2.4 | GO:0052813 | phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.5 | 1.0 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.5 | 1.4 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.5 | 1.4 | GO:0016015 | morphogen activity(GO:0016015) |
0.5 | 1.9 | GO:0031720 | haptoglobin binding(GO:0031720) |
0.5 | 1.4 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.5 | 3.2 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.5 | 2.3 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.5 | 1.4 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.5 | 2.3 | GO:0017040 | ceramidase activity(GO:0017040) |
0.4 | 1.3 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.4 | 2.6 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.4 | 7.2 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.4 | 2.5 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.4 | 1.7 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.4 | 0.8 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.4 | 1.2 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.4 | 1.2 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.4 | 4.5 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.4 | 0.8 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.4 | 2.8 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
0.4 | 1.2 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.4 | 2.0 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.4 | 7.0 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.4 | 5.8 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.4 | 8.1 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.4 | 12.3 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.4 | 1.2 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.4 | 1.9 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.4 | 4.2 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.4 | 1.9 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.4 | 1.1 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.4 | 1.9 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.4 | 1.1 | GO:0019862 | IgA binding(GO:0019862) |
0.4 | 3.2 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.3 | 4.9 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.3 | 1.0 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.3 | 0.7 | GO:0002054 | nucleobase binding(GO:0002054) |
0.3 | 1.0 | GO:2001069 | glycogen binding(GO:2001069) |
0.3 | 1.4 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.3 | 2.7 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.3 | 2.7 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.3 | 1.3 | GO:0015232 | heme transporter activity(GO:0015232) |
0.3 | 1.0 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.3 | 2.3 | GO:0034711 | inhibin binding(GO:0034711) |
0.3 | 2.6 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.3 | 2.6 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.3 | 1.0 | GO:1990190 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.3 | 2.2 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
0.3 | 0.9 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.3 | 1.6 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.3 | 4.3 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.3 | 0.9 | GO:0019961 | interferon binding(GO:0019961) |
0.3 | 0.6 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.3 | 6.1 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.3 | 2.7 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.3 | 4.5 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.3 | 1.8 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.3 | 0.9 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.3 | 2.3 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.3 | 3.2 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.3 | 1.4 | GO:1990254 | keratin filament binding(GO:1990254) |
0.3 | 1.1 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.3 | 1.7 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.3 | 1.1 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.3 | 0.8 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.3 | 1.1 | GO:0052717 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.3 | 5.0 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.3 | 0.3 | GO:1904680 | peptide transmembrane transporter activity(GO:1904680) |
0.3 | 1.9 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.3 | 7.9 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.3 | 0.3 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.3 | 10.6 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) |
0.3 | 5.9 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.3 | 2.2 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.3 | 1.1 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.3 | 1.1 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.3 | 0.8 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.3 | 1.9 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.3 | 0.8 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.3 | 2.1 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.3 | 2.9 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.3 | 1.0 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.3 | 0.5 | GO:0008494 | translation activator activity(GO:0008494) |
0.3 | 3.1 | GO:0019841 | retinol binding(GO:0019841) |
0.3 | 3.1 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.3 | 2.0 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.3 | 2.8 | GO:0010181 | FMN binding(GO:0010181) |
0.3 | 2.8 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.3 | 0.5 | GO:0032356 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.3 | 0.8 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.3 | 1.3 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.3 | 5.3 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.2 | 0.7 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.2 | 4.5 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.2 | 1.0 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.2 | 0.2 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.2 | 0.7 | GO:0004064 | arylesterase activity(GO:0004064) |
0.2 | 0.2 | GO:0030351 | inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity(GO:0030351) inositol-1,4,5,6-tetrakisphosphate 6-phosphatase activity(GO:0030352) inositol tetrakisphosphate phosphatase activity(GO:0052743) inositol pentakisphosphate phosphatase activity(GO:0052827) |
0.2 | 0.7 | GO:0036033 | mediator complex binding(GO:0036033) |
0.2 | 0.5 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.2 | 1.2 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.2 | 3.6 | GO:0016594 | glycine binding(GO:0016594) |
0.2 | 1.0 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.2 | 1.2 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.2 | 0.5 | GO:0017166 | vinculin binding(GO:0017166) |
0.2 | 0.7 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.2 | 1.2 | GO:0034452 | dynactin binding(GO:0034452) |
0.2 | 1.6 | GO:0005113 | patched binding(GO:0005113) |
0.2 | 0.7 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.2 | 0.2 | GO:0051870 | methotrexate binding(GO:0051870) |
0.2 | 0.7 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.2 | 0.7 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.2 | 0.9 | GO:0042910 | xenobiotic transporter activity(GO:0042910) |
0.2 | 1.8 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.2 | 0.2 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.2 | 4.4 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.2 | 3.3 | GO:0005521 | lamin binding(GO:0005521) |
0.2 | 0.4 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.2 | 1.1 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.2 | 1.3 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.2 | 0.2 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.2 | 1.3 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.2 | 0.2 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.2 | 2.8 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.2 | 0.6 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.2 | 3.1 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.2 | 2.3 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.2 | 0.6 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.2 | 1.0 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.2 | 1.0 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.2 | 1.8 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.2 | 0.6 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.2 | 0.6 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.2 | 0.6 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.2 | 1.3 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.2 | 0.2 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
0.2 | 0.6 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.2 | 2.3 | GO:0001618 | virus receptor activity(GO:0001618) |
0.2 | 0.6 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.2 | 0.8 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.2 | 1.1 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.2 | 0.6 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.2 | 0.7 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.2 | 0.9 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.2 | 1.3 | GO:0051184 | cofactor transporter activity(GO:0051184) |
0.2 | 0.6 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.2 | 0.6 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.2 | 0.2 | GO:0034888 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.2 | 8.4 | GO:0008907 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.2 | 0.6 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.2 | 0.9 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.2 | 2.7 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.2 | 0.9 | GO:0070728 | leucine binding(GO:0070728) |
0.2 | 0.7 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.2 | 3.2 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.2 | 3.7 | GO:0045502 | dynein binding(GO:0045502) |
0.2 | 0.4 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.2 | 0.7 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.2 | 0.7 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.2 | 0.5 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.2 | 1.6 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.2 | 1.2 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.2 | 0.5 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.2 | 1.1 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.2 | 1.6 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.2 | 0.5 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.2 | 1.8 | GO:0030332 | cyclin binding(GO:0030332) |
0.2 | 0.5 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.2 | 0.2 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.2 | 0.7 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.2 | 0.5 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.2 | 0.5 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.2 | 1.0 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.2 | 1.2 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.2 | 0.5 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.2 | 0.8 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.2 | 4.2 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.2 | 1.2 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.2 | 1.0 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.2 | 0.7 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.2 | 0.5 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.2 | 2.0 | GO:0070628 | proteasome binding(GO:0070628) |
0.2 | 3.7 | GO:0043531 | ADP binding(GO:0043531) |
0.2 | 0.2 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.2 | 0.5 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.2 | 0.2 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.2 | 1.8 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.2 | 0.5 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.2 | 1.0 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.2 | 7.6 | GO:0019209 | kinase activator activity(GO:0019209) |
0.2 | 1.0 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.2 | 1.3 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
0.2 | 7.9 | GO:0019843 | rRNA binding(GO:0019843) |
0.2 | 0.6 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.2 | 0.3 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.2 | 1.3 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.2 | 0.3 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.2 | 0.2 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
0.2 | 0.8 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.2 | 0.5 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.2 | 0.8 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.2 | 1.9 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.2 | 3.3 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.2 | 0.8 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.2 | 2.2 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.2 | 0.3 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.2 | 2.2 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.2 | 2.1 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.2 | 0.5 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.2 | 1.2 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.2 | 0.6 | GO:0031781 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.2 | 1.4 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.2 | 0.5 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.1 | 0.4 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.1 | 0.4 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.1 | 1.8 | GO:0033558 | protein deacetylase activity(GO:0033558) |
0.1 | 0.4 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.1 | 3.0 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 2.1 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 3.5 | GO:0043713 | C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity(GO:0000252) mevaldate reductase activity(GO:0004495) gluconate dehydrogenase activity(GO:0008875) epoxide dehydrogenase activity(GO:0018451) 5-exo-hydroxycamphor dehydrogenase activity(GO:0018452) 2-hydroxytetrahydrofuran dehydrogenase activity(GO:0018453) acetoin dehydrogenase activity(GO:0019152) phenylcoumaran benzylic ether reductase activity(GO:0032442) D-xylose:NADP reductase activity(GO:0032866) L-arabinose:NADP reductase activity(GO:0032867) D-arabinitol dehydrogenase, D-ribulose forming (NADP+) activity(GO:0033709) (R)-(-)-1,2,3,4-tetrahydronaphthol dehydrogenase activity(GO:0034831) 3-hydroxymenthone dehydrogenase activity(GO:0034840) very long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0035380) (R)-2-hydroxyisocaproate dehydrogenase activity(GO:0043713) L-arabinose 1-dehydrogenase (NADP+) activity(GO:0044103) L-xylulose reductase (NAD+) activity(GO:0044105) 3-ketoglucose-reductase activity(GO:0048258) D-arabinitol dehydrogenase, D-xylulose forming (NADP+) activity(GO:0052677) |
0.1 | 2.9 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 27.8 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
0.1 | 7.7 | GO:0002039 | p53 binding(GO:0002039) |
0.1 | 2.9 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.1 | 0.1 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.1 | 0.7 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.1 | 1.6 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 0.1 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.1 | 1.2 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.1 | 0.6 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.1 | 0.1 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.1 | 1.6 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 0.3 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.1 | 2.1 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 0.4 | GO:0043559 | insulin binding(GO:0043559) |
0.1 | 0.3 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.1 | 0.3 | GO:0097016 | L27 domain binding(GO:0097016) |
0.1 | 1.3 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.1 | 9.7 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
0.1 | 0.4 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.1 | 1.8 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.1 | 0.3 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.1 | 0.6 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.1 | 0.1 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.1 | 0.5 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.1 | 0.7 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 1.2 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.1 | 0.5 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 0.9 | GO:0034046 | poly(G) binding(GO:0034046) |
0.1 | 0.4 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.1 | 0.1 | GO:0035870 | dITP diphosphatase activity(GO:0035870) |
0.1 | 6.6 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 0.7 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 0.3 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.1 | 1.2 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.5 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.1 | 0.5 | GO:0042731 | PH domain binding(GO:0042731) |
0.1 | 0.3 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.1 | 0.8 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.1 | 0.4 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.1 | 1.4 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.1 | 0.5 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.1 | 1.0 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.1 | 3.2 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.1 | 0.4 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.1 | 0.4 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.1 | 0.4 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 8.6 | GO:0061659 | ubiquitin-like protein ligase activity(GO:0061659) |
0.1 | 1.4 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 0.2 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.1 | 0.7 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 0.7 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 6.0 | GO:0015923 | mannosidase activity(GO:0015923) |
0.1 | 10.9 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 6.1 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.1 | 0.4 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.1 | 0.2 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.1 | 0.8 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
0.1 | 0.7 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 1.7 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.1 | 0.5 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.1 | 0.8 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 4.3 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.1 | 1.1 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.1 | 0.4 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.1 | 0.4 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.1 | 1.1 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.4 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.1 | 2.7 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 0.1 | GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.1 | 0.4 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.1 | 0.7 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.1 | 0.7 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.1 | 0.2 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 0.5 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.1 | 0.1 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
0.1 | 0.6 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.1 | 0.5 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.1 | 0.3 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.1 | 1.1 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.1 | 7.3 | GO:0042626 | ATPase activity, coupled to transmembrane movement of substances(GO:0042626) |
0.1 | 0.3 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.1 | 2.0 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 0.7 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 2.1 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.1 | 0.6 | GO:0008933 | lytic transglycosylase activity(GO:0008933) |
0.1 | 0.2 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.1 | 0.2 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.1 | 0.1 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.1 | 0.7 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 0.7 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 0.4 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.1 | 0.2 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.1 | 0.4 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 1.2 | GO:0008143 | poly(A) binding(GO:0008143) |
0.1 | 0.3 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 0.2 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.1 | 0.5 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 0.3 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.1 | 17.2 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 0.2 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.1 | 0.2 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.1 | 2.1 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.1 | 0.9 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 1.1 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.1 | 2.8 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.1 | 3.2 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.1 | 2.9 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.1 | 0.4 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.1 | 0.9 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.1 | 0.5 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.1 | 0.4 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.1 | 0.3 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.1 | 0.7 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.1 | GO:0034618 | arginine binding(GO:0034618) |
0.1 | 0.8 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.1 | 0.7 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 1.2 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.1 | 0.4 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.5 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 0.5 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 4.2 | GO:0051117 | ATPase binding(GO:0051117) |
0.1 | 0.3 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 0.2 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.1 | 0.9 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.1 | 0.8 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.3 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.1 | 0.9 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.1 | 3.6 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.1 | 0.4 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 2.2 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.1 | 0.2 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.1 | 0.4 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.1 | 0.4 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 2.2 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.1 | 0.5 | GO:0048156 | tau protein binding(GO:0048156) |
0.1 | 0.5 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.1 | 0.2 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.1 | 1.2 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.1 | 0.3 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.1 | 0.5 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 0.3 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.1 | 0.3 | GO:0008142 | oxysterol binding(GO:0008142) |
0.1 | 0.3 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 0.4 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.1 | 0.1 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.1 | 0.4 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.1 | 0.3 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 0.5 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.1 | 0.7 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 0.7 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.1 | 0.5 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 0.7 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.1 | 1.6 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.1 | 0.3 | GO:0043199 | sulfate binding(GO:0043199) |
0.1 | 1.1 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
0.1 | 0.3 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 1.2 | GO:0030552 | cAMP binding(GO:0030552) |
0.1 | 0.3 | GO:1990405 | protein antigen binding(GO:1990405) |
0.1 | 0.1 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.1 | 0.6 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.1 | 0.6 | GO:0034863 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.1 | 0.2 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.1 | 4.9 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.1 | 0.2 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.1 | 0.2 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.1 | 1.3 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.1 | 0.2 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 0.6 | GO:0070402 | NADPH binding(GO:0070402) |
0.1 | 0.1 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.1 | 0.1 | GO:0032052 | bile acid binding(GO:0032052) |
0.1 | 0.6 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 0.4 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 1.1 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.1 | 0.2 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 0.4 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 0.5 | GO:0005123 | death receptor binding(GO:0005123) |
0.1 | 0.2 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 0.2 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.1 | 0.8 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.1 | 0.2 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.1 | 1.5 | GO:0005548 | phospholipid transporter activity(GO:0005548) |
0.1 | 0.3 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.1 | 0.1 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.1 | 0.2 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.1 | 1.3 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.1 | 0.4 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.1 | 0.9 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.1 | 1.0 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.1 | 0.9 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.1 | 0.6 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.1 | 0.2 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 0.3 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.1 | 2.1 | GO:0052771 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.1 | 0.6 | GO:0031386 | protein tag(GO:0031386) |
0.1 | 0.6 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.1 | 0.1 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 4.6 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
0.1 | 0.7 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.8 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 0.5 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.2 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 1.4 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 0.6 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.1 | 0.1 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.1 | 1.9 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 0.1 | GO:0004772 | sterol O-acyltransferase activity(GO:0004772) |
0.1 | 0.1 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) |
0.1 | 3.5 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.1 | 0.2 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.1 | 1.4 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 0.1 | GO:0000339 | RNA cap binding(GO:0000339) |
0.1 | 0.1 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.1 | 0.5 | GO:0099528 | G-protein coupled neurotransmitter receptor activity(GO:0099528) |
0.1 | 4.3 | GO:0002020 | protease binding(GO:0002020) |
0.1 | 0.3 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.1 | 0.2 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.1 | 0.7 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.1 | 0.2 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.1 | 0.2 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 0.1 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.1 | 1.6 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.1 | 0.2 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.1 | 0.3 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 0.2 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.1 | 0.1 | GO:0003933 | GTP cyclohydrolase activity(GO:0003933) |
0.1 | 0.2 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.1 | 0.1 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.1 | 0.3 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.1 | 0.3 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.1 | 0.1 | GO:0070538 | oleic acid binding(GO:0070538) |
0.1 | 0.1 | GO:0016279 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
0.1 | 0.1 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 0.1 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.1 | 0.1 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.1 | 0.4 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.1 | 5.1 | GO:0003729 | mRNA binding(GO:0003729) |
0.1 | 0.4 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.1 | 0.8 | GO:0019239 | deaminase activity(GO:0019239) |
0.1 | 0.5 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.1 | 0.1 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.1 | 0.2 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 2.6 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 0.2 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.1 | 0.7 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 0.3 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.1 | 0.7 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.1 | 0.3 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.1 | 0.3 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.1 | 0.9 | GO:0016917 | GABA-A receptor activity(GO:0004890) GABA receptor activity(GO:0016917) |
0.1 | 2.5 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 0.2 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 1.4 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.1 | 0.1 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.1 | 1.7 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 0.2 | GO:0000182 | rDNA binding(GO:0000182) |
0.1 | 0.2 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.1 | 0.5 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.1 | 2.5 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.1 | 0.9 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 1.5 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |
0.1 | 0.1 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.1 | 0.1 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.1 | 0.5 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.1 | 0.2 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.1 | 0.9 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.0 | 0.0 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.0 | 0.1 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.0 | 0.2 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.0 | 0.0 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.0 | 0.1 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.0 | 0.1 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.0 | 0.6 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 1.2 | GO:0016414 | O-octanoyltransferase activity(GO:0016414) |
0.0 | 1.0 | GO:0008757 | S-adenosylmethionine-dependent methyltransferase activity(GO:0008757) |
0.0 | 0.1 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.0 | 0.1 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 0.4 | GO:0061650 | ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.0 | 0.8 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.2 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.0 | 0.0 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.0 | 0.2 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.0 | 0.1 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.0 | 0.5 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.0 | 0.2 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.0 | 0.5 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.0 | 0.1 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.0 | 0.1 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.0 | 4.0 | GO:0008514 | organic anion transmembrane transporter activity(GO:0008514) |
0.0 | 0.2 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 0.2 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.0 | 0.8 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.1 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.0 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.0 | 0.5 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.0 | 0.1 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.0 | 0.3 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.0 | 0.0 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.0 | 0.4 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.0 | 2.2 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.0 | 0.1 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.0 | 0.1 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.0 | 0.1 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.0 | 0.2 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.1 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.0 | 4.7 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 0.1 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.0 | 0.2 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.0 | 0.5 | GO:0022840 | leak channel activity(GO:0022840) potassium ion leak channel activity(GO:0022841) narrow pore channel activity(GO:0022842) |
0.0 | 0.0 | GO:0018585 | fluorene oxygenase activity(GO:0018585) |
0.0 | 0.1 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.0 | 0.1 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.0 | 1.8 | GO:0019887 | protein kinase regulator activity(GO:0019887) |
0.0 | 0.2 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.2 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.0 | 0.1 | GO:0031433 | telethonin binding(GO:0031433) |
0.0 | 0.1 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.0 | 1.3 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.0 | 0.8 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.3 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.0 | 5.5 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.1 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.0 | 0.1 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 0.1 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.0 | 0.9 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.0 | 0.5 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.1 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 0.1 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.1 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.0 | 0.7 | GO:0005504 | fatty acid binding(GO:0005504) |
0.0 | 0.2 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.1 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.0 | 0.2 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 0.0 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.0 | 0.1 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.0 | 0.3 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.0 | 0.1 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.0 | 0.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.1 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.0 | 0.1 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.0 | 0.8 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 0.1 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.0 | 0.1 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.0 | 0.0 | GO:0019002 | GMP binding(GO:0019002) |
0.0 | 0.2 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.0 | 0.1 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.0 | 0.5 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.1 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.0 | 0.1 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.0 | 3.4 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 0.1 | GO:0000828 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.0 | 0.1 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.0 | 0.0 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.0 | 0.1 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.0 | 0.2 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.0 | 0.1 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.0 | 0.2 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.0 | 0.5 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.0 | 0.0 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.0 | 0.1 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.0 | 0.8 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.9 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 0.0 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.0 | 0.7 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.0 | 0.2 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.0 | 0.8 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.0 | 0.1 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.0 | 0.9 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.0 | 0.1 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.0 | 0.3 | GO:0016776 | phosphotransferase activity, phosphate group as acceptor(GO:0016776) |
0.0 | 0.0 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.0 | 0.1 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.0 | 0.0 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.0 | 0.1 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.0 | 0.2 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.0 | 10.0 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.0 | 0.1 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.0 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.0 | 0.0 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 0.1 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.0 | 0.0 | GO:0003916 | DNA topoisomerase activity(GO:0003916) DNA topoisomerase type I activity(GO:0003917) |
0.0 | 0.1 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.0 | 0.1 | GO:0000217 | DNA secondary structure binding(GO:0000217) |
0.0 | 0.1 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.0 | 0.1 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.1 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.0 | 0.5 | GO:0005272 | sodium channel activity(GO:0005272) |
0.0 | 0.1 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.0 | 0.0 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.0 | 0.2 | GO:0005254 | chloride channel activity(GO:0005254) |
0.0 | 1.6 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.1 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) |
0.0 | 0.1 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.0 | 0.0 | GO:0030523 | S-acetyltransferase activity(GO:0016418) dihydrolipoamide S-acyltransferase activity(GO:0030523) |
0.0 | 0.0 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.0 | 0.0 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.0 | 0.1 | GO:0005319 | lipid transporter activity(GO:0005319) |
0.0 | 0.0 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.0 | 0.0 | GO:0016415 | octanoyltransferase activity(GO:0016415) |
0.0 | 0.1 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.1 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.0 | 0.5 | GO:0044325 | ion channel binding(GO:0044325) |
0.0 | 0.1 | GO:0016878 | acid-thiol ligase activity(GO:0016878) |
0.0 | 0.1 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.0 | 0.0 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.0 | 0.0 | GO:0019808 | polyamine binding(GO:0019808) |
0.0 | 0.1 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 0.0 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.0 | 0.0 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.0 | 0.0 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.0 | 0.1 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.0 | 0.1 | GO:0030506 | ankyrin binding(GO:0030506) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 6.5 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.5 | 0.5 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.4 | 5.7 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.3 | 4.2 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.3 | 3.0 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.3 | 7.6 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.2 | 6.9 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.2 | 1.6 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.2 | 8.1 | PID AURORA B PATHWAY | Aurora B signaling |
0.2 | 3.3 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.2 | 4.3 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.2 | 4.3 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.2 | 4.3 | PID BARD1 PATHWAY | BARD1 signaling events |
0.2 | 2.4 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.2 | 0.5 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.2 | 1.4 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.2 | 5.1 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.2 | 0.3 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.2 | 2.3 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 5.1 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 0.6 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 2.7 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 2.5 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 1.6 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 2.2 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 1.6 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 0.5 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 2.7 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 0.9 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 2.8 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 5.2 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 1.7 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 0.8 | PID IGF1 PATHWAY | IGF1 pathway |
0.1 | 0.2 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 2.2 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 1.6 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 2.2 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 3.3 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 2.8 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 1.9 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 3.1 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 1.6 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 0.4 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 0.2 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.1 | 1.3 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 2.9 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.1 | 1.9 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 0.7 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 0.6 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 0.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 1.5 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.1 | 0.8 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 1.0 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 0.3 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 0.9 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 0.2 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 2.8 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 0.9 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 2.3 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.1 | 1.3 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 1.5 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 0.1 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.1 | 1.3 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.1 | 0.4 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 0.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 0.7 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.6 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.0 | 0.4 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.0 | 0.2 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.0 | 1.3 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 2.0 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 0.2 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 1.7 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.5 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 1.2 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 0.7 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 1.4 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 0.4 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 0.6 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 0.4 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.1 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 0.3 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.3 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 0.0 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.1 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.3 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 0.2 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 0.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.2 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 0.0 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.0 | 0.3 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 0.5 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.2 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 0.6 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 0.0 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 0.1 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.0 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.0 | 0.3 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 0.1 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 0.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.1 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.0 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 0.1 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 9.2 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.9 | 12.7 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.7 | 7.5 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.6 | 8.8 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.5 | 7.2 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.5 | 7.9 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.4 | 5.3 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.4 | 5.7 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.4 | 3.9 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.4 | 5.1 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.4 | 4.3 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.4 | 6.2 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.4 | 1.5 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.4 | 5.3 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.4 | 7.4 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.4 | 6.1 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.3 | 4.9 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.3 | 9.6 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.3 | 3.4 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.3 | 0.3 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.3 | 3.3 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.3 | 1.0 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.3 | 1.9 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.3 | 5.3 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.3 | 3.0 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.3 | 0.6 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.3 | 2.4 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.3 | 3.2 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.3 | 5.1 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.3 | 3.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.3 | 2.7 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.3 | 13.1 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.3 | 2.4 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.2 | 3.2 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.2 | 0.5 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.2 | 5.6 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.2 | 4.9 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.2 | 1.9 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.2 | 3.1 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.2 | 3.1 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.2 | 3.1 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.2 | 1.6 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.2 | 2.1 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.2 | 0.7 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.2 | 2.5 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.2 | 9.7 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.2 | 4.9 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.2 | 0.7 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.2 | 0.2 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.2 | 0.2 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.2 | 5.8 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.2 | 3.8 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.2 | 2.2 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.2 | 1.4 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.2 | 1.9 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.2 | 0.8 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.2 | 1.3 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.2 | 3.1 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.2 | 3.0 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.2 | 5.2 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.2 | 0.2 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.2 | 4.9 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.2 | 2.7 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.2 | 1.8 | REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
0.2 | 0.5 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.2 | 1.9 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.2 | 1.7 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.2 | 2.4 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.2 | 1.9 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
0.2 | 2.4 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.2 | 2.9 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.2 | 0.9 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.2 | 1.7 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.2 | 2.8 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.2 | 1.3 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.2 | 0.2 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.2 | 0.5 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.2 | 4.0 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.2 | 2.1 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.2 | 0.6 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.2 | 0.3 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.2 | 4.8 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.2 | 2.1 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.2 | 1.6 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.2 | 2.7 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.2 | 1.3 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.2 | 0.8 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.2 | 1.2 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.2 | 0.3 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.1 | 0.7 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 0.3 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.1 | 4.0 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.1 | 0.4 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.1 | 0.3 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.1 | 5.5 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.1 | 2.3 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 3.6 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.1 | 0.5 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 0.7 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.1 | 2.5 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 1.5 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.1 | 0.9 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.1 | 1.5 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 1.7 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.1 | 0.3 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.1 | 4.5 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.1 | 0.3 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.1 | 0.3 | REACTOME ORC1 REMOVAL FROM CHROMATIN | Genes involved in Orc1 removal from chromatin |
0.1 | 9.6 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 1.0 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 1.8 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 1.9 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.1 | 0.9 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.1 | 0.8 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.1 | 2.6 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.1 | 1.1 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.1 | 0.7 | REACTOME RNA POL II PRE TRANSCRIPTION EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |
0.1 | 3.6 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 0.9 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.1 | 0.8 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.1 | 0.3 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.1 | 0.3 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
0.1 | 0.2 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 3.4 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 0.8 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.1 | 0.6 | REACTOME MITOTIC G2 G2 M PHASES | Genes involved in Mitotic G2-G2/M phases |
0.1 | 1.1 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 1.8 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.1 | 1.9 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.1 | 0.7 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 1.0 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 0.6 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.1 | 2.4 | REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION | Genes involved in Cleavage of Growing Transcript in the Termination Region |
0.1 | 1.0 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 0.5 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 0.1 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 10.4 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 0.1 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.1 | 0.3 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.1 | 5.2 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.1 | 0.8 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.1 | 6.4 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.1 | 1.7 | REACTOME CELL CYCLE CHECKPOINTS | Genes involved in Cell Cycle Checkpoints |
0.1 | 0.2 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.1 | 0.1 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 0.9 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 0.4 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.1 | 0.9 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 1.6 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.1 | 3.4 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 1.5 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.1 | 0.4 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 1.6 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 0.4 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 0.3 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.1 | 0.6 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.1 | 0.5 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 0.7 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 0.4 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 5.1 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 1.9 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 0.6 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 3.1 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 0.1 | REACTOME KINESINS | Genes involved in Kinesins |
0.1 | 1.1 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.1 | 1.5 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 0.2 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.1 | 0.9 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 0.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.1 | 0.6 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.1 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.0 | 0.6 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.3 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.0 | 0.1 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 0.5 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 0.1 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.0 | 0.0 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.0 | 1.0 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 0.2 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.4 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 1.6 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.0 | 0.7 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.5 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.0 | 0.8 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.0 | 1.1 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.0 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.0 | 0.0 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.4 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 0.2 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 0.2 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.0 | 0.6 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 1.0 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.0 | 1.3 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 1.1 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.1 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
0.0 | 0.1 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.0 | 0.1 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.0 | 0.2 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.2 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.2 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.0 | 0.3 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.0 | 0.2 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.0 | 0.1 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.0 | 0.2 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.0 | 0.1 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.0 | 0.0 | REACTOME CYTOKINE SIGNALING IN IMMUNE SYSTEM | Genes involved in Cytokine Signaling in Immune system |
0.0 | 0.4 | REACTOME TRANSLATION | Genes involved in Translation |
0.0 | 0.4 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.0 | 0.0 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.0 | 0.1 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.0 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.0 | 0.2 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.1 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.0 | 0.1 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |